hg_121601.1

Basic information about the TSS

---

TSS ID: hg_121601.1 Species: human Chr: chr11		Start: 83285953 End: 83285964 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000533761.5 ENST00000530253.5 Distance: 0 GeneID: 60492 HGNC/MGI_ID: HGNC:28108 UniProt_ID: H0YD95

Gene_name: coiled-coil domain containing 90B Gene_symbol: CCDC90B Gene_synonyms: MDS011 MDS025 Gene_source: HGNC:28108

TATA-Box annotation

---

Distance to TSS:	448
Nearest PromoterID:	NM_001286120
Entrez ID:	60492
Nearest Unigene:	Hs.368866
Nearest Refseq:	NM_021825
Nearest Ensembl:	ENSG00000137500
Gene Name:	coiled-coil domain containing 90B
Gene Alias:	MDS011|MDS025
Gene Description:	coiled-coil domain containing 90B
Gene Type:	protein-coding
CpG%:	0.07
GC%:	0.61194
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CCDC90B p2@CCDC90B p3@CCDC90B p4@CCDC90B p5@CCDC90B p6@CCDC90B p7@CCDC90B p8@CCDC90B p9@CCDC90B
Sample		p1@CCDC90B	p2@CCDC90B	p3@CCDC90B	p4@CCDC90B	p5@CCDC90B	p6@CCDC90B	p7@CCDC90B	p8@CCDC90B	p9@CCDC90B
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	4.68	14.03	0.39	0.39	0.39	0.39	0.00	0.00	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	4.25	18.82	0.40	0.00	0.40	1.42	0.00	0.20	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	5.59	18.13	0.00	0.58	0.19	0.77	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	5.20	16.84	0.62	0.42	0.21	1.87	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	4.50	14.85	0.90	0.22	0.00	0.90	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	4.65	16.47	0.19	0.39	0.39	0.78	0.00	0.19	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	10.02	32.25	0.00	0.44	0.00	1.09	0.00	0.00	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	7.02	24.71	0.48	0.73	0.73	1.70	0.00	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	5.98	17.95	0.64	0.43	0.64	1.50	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	11.59	50.43	0.00	0.58	0.00	1.16	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	6.06	49.32	0.00	0.81	0.40	2.83	0.00	0.40	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	6.10	45.53	0.81	0.00	2.03	1.63	0.00	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	35.62	5.80	2.26	2.58	1.61	0.16	0.32	1.61	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	34.73	6.92	2.10	2.71	1.65	0.00	0.30	0.75	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	37.10	7.46	2.85	3.51	1.32	0.66	0.00	1.76	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	28.92	6.04	0.75	1.76	1.26	0.25	0.75	1.26	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	32.32	5.68	2.62	1.53	1.31	0.44	0.66	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	27.00	8.01	2.11	0.84	2.53	0.42	0.42	1.69	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	30.92	6.40	2.13	2.13	0.53	0.00	0.00	1.07	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	38.81	6.62	2.26	1.20	1.35	0.45	0.15	0.75	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	35.42	7.35	2.41	2.94	1.47	0.00	0.00	0.80	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	36.94	6.39	1.90	1.90	2.24	0.17	1.04	1.90	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	28.31	5.30	2.33	1.03	1.16	0.13	0.00	0.90	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	33.49	6.07	1.46	2.91	1.21	0.00	0.24	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	32.76	6.45	3.10	2.06	1.81	0.26	0.26	0.52	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	36.08	6.33	1.27	2.53	1.90	0.63	0.63	1.27	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	29.67	9.89	0.55	2.20	1.10	0.00	0.00	1.10	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	38.43	7.07	5.66	0.94	1.41	0.00	0.24	0.94	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	32.95	6.78	2.26	1.94	1.29	0.48	0.16	0.16	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	27.14	6.15	2.53	2.35	1.09	0.00	0.54	0.72	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	31.19	7.12	0.84	1.67	1.47	0.21	0.42	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	24.23	6.64	1.56	2.34	0.78	0.59	0.00	0.39	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	25.75	7.60	1.90	2.53	1.06	0.42	0.42	1.27	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	34.47	9.24	3.30	3.46	0.99	0.16	0.33	1.32	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	33.28	6.54	2.43	2.43	0.75	0.00	0.19	0.75	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	27.59	6.13	1.15	2.11	0.77	0.19	0.19	0.57	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	30.66	7.36	2.25	0.82	1.43	0.00	0.20	1.02	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	27.20	5.24	1.21	2.82	0.20	0.40	0.40	0.60	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	35.38	9.18	1.62	2.97	1.89	0.54	0.27	0.54	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	28.09	6.24	2.16	1.68	1.44	0.48	0.24	1.44	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	24.00	5.65	2.59	2.12	0.94	0.47	0.47	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	30.16	8.64	2.05	1.32	1.02	0.29	0.59	0.44	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	36.27	6.75	2.11	1.90	1.90	0.21	0.21	1.05	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	26.92	5.24	1.92	2.62	2.10	0.00	0.00	0.52	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	35.54	8.63	2.01	2.41	1.20	0.20	0.20	0.60	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	31.87	7.21	2.56	1.63	0.70	0.00	0.23	1.86	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	27.83	6.00	1.44	2.64	1.92	0.00	0.00	1.20	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	37.55	6.86	4.17	6.86	1.19	0.30	0.00	1.49	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	34.71	6.22	1.91	1.91	2.15	0.00	0.00	0.72	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	37.41	7.08	3.03	1.42	1.62	0.40	0.40	0.61	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	35.05	9.22	1.02	1.23	2.66	0.20	0.00	0.41	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	38.25	7.56	2.67	1.33	1.11	0.22	0.00	2.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	139.92	27.98	0.00	41.98	0.00	0.00	0.00	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	22.00	5.68	1.06	1.77	2.13	0.00	0.35	1.06	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	25.85	5.96	1.66	0.00	0.99	0.33	0.00	1.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	77.18	11.75	12.58	2.52	2.52	0.84	1.68	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	40.87	11.48	2.76	0.92	0.92	0.46	0.00	0.92	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	38.89	6.16	0.00	2.27	0.65	0.00	0.00	1.94	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	27.30	6.74	2.25	0.96	2.25	0.32	0.64	2.25	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	44.63	9.12	1.89	4.09	1.26	0.63	0.31	1.89	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	28.91	10.58	0.00	3.53	0.71	0.00	0.00	2.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	24.11	5.05	0.00	0.00	0.56	0.56	0.00	1.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	35.03	5.57	2.39	1.59	0.80	1.59	0.00	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	42.13	7.14	3.06	2.04	2.38	1.02	0.34	1.02	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	36.07	6.50	1.30	0.65	2.27	0.32	0.32	1.62	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	41.18	4.97	0.71	1.06	0.71	0.71	0.00	1.77	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	161.64	16.16	0.00	16.16	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	181.64	0.00	15.79	0.00	15.79	7.90	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	29.25	4.88	1.95	0.49	0.98	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	29.75	3.47	0.99	0.00	1.49	0.50	0.00	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	32.37	3.75	1.88	0.00	0.47	0.94	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	36.76	4.31	0.66	1.66	1.66	0.00	0.00	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	33.72	2.47	2.17	0.93	0.62	0.31	0.00	0.93	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	30.88	5.50	0.61	0.31	0.61	0.00	0.00	0.00	0.61
Adipocyte - breast, donor1	11376-118A8	26.45	7.44	1.27	1.90	1.58	0.95	0.16	0.48	0.48
Adipocyte - breast, donor2	11327-117E4	18.29	6.42	1.76	1.76	1.12	0.32	0.32	0.00	0.00
Adipocyte - omental, donor1	11473-119C6	31.04	10.81	2.29	2.04	2.42	0.25	0.38	0.64	0.25
Adipocyte - omental, donor2	11474-119C7	10.46	5.23	2.99	2.24	1.49	0.00	0.00	0.00	0.75
Adipocyte - omental, donor3	11475-119C8	15.07	6.03	0.67	3.35	1.00	0.33	0.67	1.00	0.67
Adipocyte - perirenal, donor1	11476-119C9	16.59	6.38	0.64	1.91	1.91	0.64	0.00	1.91	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	7.70	2.20	0.00	0.00	0.00	1.10	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	15.36	2.71	0.45	0.45	0.00	0.45	0.00	0.90	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	11.99	6.08	0.87	1.56	0.87	0.87	0.52	0.00	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	30.70	6.26	2.93	2.15	0.78	0.00	0.00	0.20	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	17.24	4.63	0.51	0.77	1.03	0.00	0.00	0.26	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	23.14	6.97	1.95	1.12	1.67	0.00	0.00	0.28	1.12
Adipocyte differentiation, day04, donor4	13028-139E4	20.57	7.64	0.59	3.53	0.59	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	37.00	16.57	3.30	4.02	1.69	0.88	0.64	0.40	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	21.62	5.16	1.94	1.94	1.29	0.00	0.32	0.32	1.29
Adipocyte differentiation, day08, donor3	13026-139E2	15.46	6.40	3.20	0.53	1.07	0.00	0.53	0.53	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	16.14	10.02	2.23	0.00	0.56	0.56	1.11	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	19.96	7.90	2.08	1.25	1.66	0.42	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	21.60	5.53	0.75	0.25	0.25	0.25	0.00	0.00	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	19.31	7.85	1.64	1.64	1.31	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	18.27	8.53	2.13	0.30	0.91	0.00	0.00	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	17.90	4.64	0.66	0.44	0.88	0.44	0.00	0.44	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	1.43	0.72	0.36	0.00	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	4.79	1.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	11.87	3.96	0.72	0.18	0.36	0.18	0.00	0.00	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	10.04	3.35	0.00	0.00	0.00	0.00	0.00	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	14.18	4.31	0.62	0.62	0.41	0.41	0.00	0.00	0.21
Anulus Pulposus Cell, donor1	11248-116E6	35.24	5.95	5.15	4.69	1.49	0.23	0.23	0.23	1.26
Anulus Pulposus Cell, donor2	11463-119B5	16.16	3.18	2.69	3.18	0.49	0.24	0.00	0.73	0.73
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	26.96	7.19	2.25	2.70	0.45	0.45	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	24.31	7.38	5.21	2.60	0.43	0.43	0.00	0.00	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	32.10	6.42	4.28	2.14	2.14	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	29.00	7.17	3.29	2.99	1.49	0.60	0.30	0.00	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	39.20	6.32	6.32	2.53	1.26	0.00	0.00	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	26.40	4.62	2.64	1.32	0.00	0.66	0.66	0.66	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	25.67	4.87	2.27	1.62	0.65	0.00	0.00	0.00	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	24.27	5.83	3.88	0.00	1.46	0.00	0.00	0.00	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	22.57	3.56	1.19	1.19	0.59	0.59	0.59	0.59	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	32.01	6.40	3.77	3.01	0.38	0.00	0.00	0.38	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	26.85	5.08	3.63	1.45	0.73	0.73	0.00	0.00	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	27.58	6.27	1.25	1.25	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	36.08	9.72	4.78	1.48	1.98	0.66	0.00	0.66	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	30.03	4.09	1.36	1.36	1.36	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	30.76	5.73	3.32	2.87	1.51	0.45	0.15	0.30	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	30.00	9.11	6.43	0.54	1.07	0.54	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	24.56	4.53	2.83	2.27	1.32	0.57	0.00	0.57	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	36.89	6.15	2.67	1.34	1.60	0.27	0.00	1.07	1.87
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	33.17	6.83	2.93	0.00	0.00	1.95	0.00	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	30.02	4.15	3.15	1.66	2.49	0.00	0.17	0.83	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	24.01	6.00	3.60	1.20	1.20	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	31.86	7.08	3.54	3.54	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	25.90	7.20	2.06	1.72	0.69	0.17	0.00	0.17	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	8.39	8.39	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	24.27	5.34	6.31	3.40	1.94	0.00	0.49	0.49	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	37.95	6.07	2.28	3.79	0.00	0.38	0.00	0.38	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	33.92	7.27	1.21	1.21	1.21	0.00	0.00	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	32.49	3.99	3.99	0.57	1.14	1.14	0.00	0.57	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	29.29	7.05	3.42	2.35	0.86	0.21	0.00	0.21	1.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	29.42	6.45	3.61	1.29	0.77	0.00	0.00	1.55	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	20.18	3.28	1.41	0.94	1.88	0.47	0.00	0.47	1.88
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	22.51	8.04	5.14	3.86	0.64	0.64	0.00	0.96	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	23.54	6.42	3.57	2.14	4.28	0.00	0.00	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	22.23	5.85	4.09	1.17	0.00	0.00	0.00	0.58	1.17
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	34.02	5.12	2.71	1.81	1.51	0.30	0.30	0.60	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	24.95	4.75	1.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	28.48	5.59	2.54	1.02	1.53	0.00	0.00	1.02	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	30.31	6.88	4.33	0.76	1.02	0.25	0.00	0.25	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	19.06	3.18	2.54	1.27	1.27	0.64	0.00	0.64	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	28.91	5.18	3.02	0.86	2.16	1.29	0.00	0.00	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	30.27	5.72	2.96	1.69	1.06	0.00	0.00	0.21	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	26.39	4.35	1.45	1.16	0.29	0.58	0.58	1.16	1.16
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	27.40	3.78	3.78	1.89	0.94	0.00	0.00	1.89	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	29.33	6.44	2.03	2.71	0.51	0.34	0.00	0.85	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	20.85	9.27	2.32	0.00	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	23.24	8.45	2.11	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	28.09	4.50	3.22	1.50	0.86	0.21	0.00	0.64	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	25.27	4.81	1.80	0.00	0.60	0.00	0.00	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	19.68	5.83	2.92	2.92	0.73	0.00	0.73	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	31.26	3.22	3.22	1.84	1.38	0.23	0.00	0.23	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	5.10	0.00	2.55	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	38.64	5.85	3.81	1.78	1.02	0.51	0.76	1.53	0.76
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	35.30	8.05	2.68	1.86	1.24	0.62	0.00	0.83	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	26.93	4.90	3.06	2.75	1.53	0.31	0.00	0.00	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	22.47	9.08	3.35	2.39	0.00	0.96	0.00	0.96	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	30.16	7.10	2.22	1.11	2.44	0.44	0.22	0.22	0.89
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	25.94	7.63	6.10	3.05	3.05	0.00	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	28.80	9.97	2.22	1.11	1.11	0.00	0.55	0.00	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	30.45	6.09	2.38	1.32	1.06	0.53	0.00	0.26	1.06
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	27.26	5.45	2.18	0.36	0.73	0.36	0.00	1.45	0.00
Astrocyte - cerebellum, donor1	11500-119F6	15.11	4.42	1.97	1.11	0.98	0.25	0.12	0.12	0.12
Astrocyte - cerebellum, donor2	11580-120F5	9.41	3.25	0.34	1.03	0.34	0.00	0.00	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	8.18	2.10	0.42	0.42	0.42	0.21	0.00	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	54.38	13.94	5.23	5.23	2.44	0.35	0.00	0.35	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	43.03	8.57	2.59	5.82	2.10	0.49	0.00	0.16	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	43.41	8.05	2.98	5.22	2.68	0.45	0.15	0.15	0.89
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	26.84	13.65	3.44	1.72	0.34	0.00	1.26	0.46	0.80
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	29.57	14.91	3.76	2.13	1.13	0.88	1.38	0.63	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	29.25	14.11	3.64	1.71	0.11	0.57	0.91	0.57	0.68
Basophils, donor1	12241-129G9	11.77	7.58	0.78	1.05	0.00	0.52	0.00	0.00	0.00
Basophils, donor2	12242-129H1	18.04	12.63	0.00	0.00	1.08	0.00	0.36	0.36	0.00
Basophils, donor3	12243-129H2	8.67	7.94	1.62	0.29	0.15	0.00	0.00	0.15	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	6.04	1.29	0.86	0.43	0.43	0.22	0.65	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	1.83	1.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	0.00	0.00	0.00	0.00	0.00	14.35	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	12.55	8.16	1.26	0.00	1.26	0.00	1.88	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	4.57	1.46	0.42	0.00	0.21	0.42	0.21	0.00	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	8.52	3.45	0.69	0.46	0.00	0.00	0.69	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	16.38	1.98	1.62	0.36	0.18	0.00	2.16	0.18	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	52.15	15.66	3.30	4.33	4.33	0.62	1.03	0.52	1.55
Burkitt's lymphoma cell line:RAJI	10476-106I8	27.72	19.56	2.10	2.56	1.63	1.16	0.23	0.47	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	37.41	14.39	2.88	1.60	1.92	0.32	0.32	0.32	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	10.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	7.33	6.76	0.56	1.69	0.00	0.00	0.56	0.00	1.13
CD14+ Monocytes, donor2	11305-117B9	5.38	6.12	0.19	0.00	0.19	0.19	0.19	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	7.24	9.22	0.44	0.88	0.22	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	21.23	7.36	3.68	0.85	0.28	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	28.05	8.34	3.03	1.52	1.14	0.00	0.00	0.38	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	30.57	7.23	1.64	0.33	0.33	0.33	0.00	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	16.33	8.67	1.01	0.29	0.72	0.14	0.00	0.14	0.87
CD14+ monocytes - mock treated, donor2	11873-125C1	13.58	6.03	0.91	0.00	0.91	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	21.32	6.16	1.42	0.47	0.47	0.24	0.00	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	13.39	7.03	0.50	0.84	0.67	0.00	0.00	0.17	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	8.56	5.52	0.00	0.28	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	15.62	4.46	0.99	0.99	0.99	0.00	0.00	0.00	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	12.34	5.29	0.39	0.00	0.20	0.00	0.00	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	8.37	4.10	0.18	0.18	0.00	0.00	0.00	0.00	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	16.76	7.62	1.96	0.87	0.44	0.22	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	8.19	3.98	0.47	0.00	0.23	0.23	0.23	0.00	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	8.98	7.39	0.53	1.06	0.53	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	11.09	8.87	3.33	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	13.39	5.35	0.89	0.74	0.30	0.00	0.00	0.30	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	14.17	5.79	0.60	0.20	0.40	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	21.65	9.58	2.29	0.21	1.46	0.21	0.00	0.00	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	9.15	5.95	0.46	0.46	0.00	0.23	0.00	0.00	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	9.50	5.20	0.45	0.45	0.90	0.23	0.00	0.45	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	9.17	3.06	1.31	1.31	0.44	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	13.18	8.34	1.88	0.54	0.00	0.00	0.00	0.27	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	14.65	6.63	0.70	0.35	0.35	0.00	0.00	0.35	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	22.72	9.26	0.84	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	9.74	5.33	1.29	0.00	0.18	0.00	0.00	0.18	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	11.27	3.87	0.70	0.35	0.00	0.00	0.35	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	12.72	4.39	0.44	0.00	0.00	0.00	0.00	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	9.07	5.23	0.52	0.52	0.17	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	7.43	4.83	0.00	0.37	0.37	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	17.46	10.56	1.29	1.29	0.86	0.22	0.00	0.00	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	11.47	5.32	0.82	0.00	0.41	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	8.81	3.71	0.23	0.00	0.93	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	14.15	6.96	0.70	0.70	1.16	0.00	0.23	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	27.46	7.85	1.09	0.65	0.00	0.00	0.00	0.44	0.87
CD14+CD16+ Monocytes, donor2	11801-124D1	18.71	8.55	2.31	1.39	0.92	0.00	0.23	0.00	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	21.23	10.18	1.08	0.22	1.08	0.00	0.00	0.22	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	17.44	13.08	2.02	0.78	0.16	0.16	0.00	0.00	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	12.57	8.73	2.97	0.52	0.35	0.00	0.00	0.00	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	20.29	12.49	1.78	0.22	0.67	0.00	0.00	0.45	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	29.60	12.25	2.30	0.26	0.51	0.00	0.00	0.26	0.77
CD14-CD16+ Monocytes, donor2	11800-124C9	27.67	10.54	7.47	0.88	0.88	0.00	0.00	0.00	0.88
CD14-CD16+ Monocytes, donor3	11911-125G3	34.32	15.79	2.53	0.63	0.63	0.00	0.00	0.42	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	81.29	20.32	2.03	4.06	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	58.98	16.27	4.07	2.03	1.36	0.68	0.00	0.68	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	65.24	19.68	2.07	1.04	0.00	0.00	1.04	0.00	4.14
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	75.69	24.52	3.73	1.60	0.00	1.07	0.00	0.53	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	70.76	21.44	2.14	1.61	1.07	0.54	0.00	0.00	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	56.86	25.27	1.40	2.11	1.40	0.00	0.70	0.70	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	57.26	26.67	3.14	2.35	0.00	0.00	0.00	0.78	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	51.41	29.00	2.64	2.64	2.64	0.00	0.00	0.00	2.64
CD19+ B Cells, donor1	11544-120B5	23.01	24.66	1.64	4.11	0.82	0.00	0.00	0.00	1.64
CD19+ B Cells, donor2	11624-122B4	13.78	18.14	0.00	3.63	0.00	0.00	0.00	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	13.13	17.16	0.50	2.02	0.00	1.01	0.00	1.01	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	22.63	28.69	2.42	0.00	0.40	2.42	0.00	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	19.58	15.58	1.60	0.00	0.00	0.40	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	14.06	9.04	2.01	0.00	0.00	1.00	0.00	0.00	2.01
CD34+ Progenitors, donor2	11625-122B5	8.99	15.73	1.69	1.12	0.00	1.12	0.00	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	34.19	7.89	4.51	2.25	2.63	1.13	0.38	1.50	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	42.17	13.08	4.06	3.83	1.13	0.23	0.00	0.45	1.13
CD4+ T Cells, donor1	11225-116C1	23.92	20.35	2.50	1.07	1.07	0.00	0.36	0.00	1.07
CD4+ T Cells, donor2	11306-117C1	20.82	21.43	2.45	4.90	0.61	0.61	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	16.77	18.30	1.22	7.62	0.30	0.00	0.30	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	36.24	7.66	2.81	1.53	1.53	0.26	0.00	0.51	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	44.02	12.13	4.72	1.80	1.35	0.00	0.00	1.80	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	50.02	10.92	2.01	0.86	1.72	0.29	0.00	1.15	1.15
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	41.72	31.76	2.84	1.42	0.47	0.00	0.00	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	51.27	28.80	7.02	3.51	1.40	1.40	0.70	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	56.04	26.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	31.36	8.67	3.03	1.01	1.16	0.14	0.14	0.14	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	33.38	8.98	4.74	3.05	0.34	0.17	0.34	0.51	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	30.47	8.06	2.90	0.81	0.81	0.48	0.16	0.64	0.48
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	44.83	21.07	3.14	1.79	0.45	0.00	0.00	0.90	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	39.13	24.11	3.49	1.40	1.40	1.05	0.00	0.35	2.45
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	41.80	22.44	1.32	0.44	0.00	0.44	0.00	0.00	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	32.47	13.91	2.95	1.69	0.42	0.84	1.26	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	35.94	8.93	3.95	2.49	0.83	0.21	0.00	0.21	0.62
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	29.74	14.03	2.00	1.00	0.00	0.33	0.00	1.00	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	38.89	23.93	1.09	0.82	0.00	0.54	0.27	0.00	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	43.41	26.26	4.29	2.68	0.54	0.54	0.00	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	30.48	14.35	0.00	0.00	0.00	0.00	0.00	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	32.45	16.13	3.52	0.74	1.11	0.37	0.19	0.37	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	30.33	11.70	3.68	2.60	0.87	0.00	0.43	0.65	1.08
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	33.20	12.82	3.78	2.10	0.63	0.63	0.00	0.42	0.84
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	45.00	17.70	2.02	2.53	1.52	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	34.23	25.56	2.60	4.33	0.87	0.00	0.43	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	40.53	24.41	3.49	1.74	1.74	1.31	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	63.84	17.82	3.46	0.49	0.49	0.49	0.00	0.00	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	56.31	17.54	2.77	0.00	0.92	0.00	0.00	0.00	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	86.54	22.33	8.37	2.79	1.40	0.00	0.00	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	38.49	18.55	2.77	0.83	1.66	0.00	0.00	0.55	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	42.21	23.56	3.93	0.74	2.21	0.00	0.00	0.25	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	61.60	15.40	4.62	1.54	3.08	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	64.82	13.97	2.86	1.43	1.07	0.00	0.00	0.00	1.07
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	58.17	20.77	4.15	0.00	1.38	0.00	0.00	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	22.59	16.70	1.31	4.58	0.33	0.00	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	14.64	14.27	0.38	3.75	0.00	0.00	0.38	0.00	0.75
CD8+ T Cells, donor3	11383-118B6	19.44	23.99	0.50	2.78	0.50	0.25	0.00	0.00	0.76
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	11.70	6.88	1.61	1.15	0.23	0.23	0.92	0.23	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	12.46	6.47	1.92	1.20	0.48	0.24	0.72	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	13.95	9.58	0.82	1.09	0.27	0.27	1.09	0.27	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	19.51	7.51	1.80	0.60	0.60	0.60	1.20	0.30	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	12.24	5.28	0.48	1.20	0.24	0.48	0.24	0.24	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	12.28	7.50	0.45	0.91	0.23	0.45	1.14	0.68	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	12.60	6.30	2.17	1.74	0.87	0.43	0.43	0.22	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	12.37	7.11	1.58	1.05	0.53	0.00	0.00	0.53	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	14.54	6.80	1.17	0.23	1.88	0.94	0.47	0.47	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	14.49	6.34	1.51	1.21	2.72	1.21	0.60	1.21	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	22.95	6.39	1.45	0.58	1.16	0.87	2.03	0.87	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	18.92	6.66	1.07	1.07	1.07	1.07	1.07	0.27	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	13.13	4.38	0.88	0.00	0.88	0.44	0.44	0.88	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	11.84	5.01	1.37	2.28	0.91	0.00	0.91	0.46	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	14.17	3.73	0.00	1.49	0.00	0.00	0.00	2.24	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	14.41	10.08	1.44	1.08	1.08	0.72	0.00	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	12.37	9.21	1.73	1.44	0.86	0.29	0.29	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	12.73	7.07	1.41	0.71	0.71	0.24	0.71	0.71	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	17.75	6.02	0.32	1.27	0.32	0.00	0.00	0.95	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	12.92	6.15	1.23	0.62	0.62	0.62	0.00	1.54	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	14.43	5.77	1.92	0.96	0.64	0.64	1.28	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	16.45	8.41	1.15	1.53	0.38	0.76	0.76	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	17.73	5.12	3.15	1.97	0.39	0.79	1.97	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	14.37	6.81	2.27	1.51	0.76	0.00	0.00	0.76	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	33.72	4.82	4.82	1.61	4.82	0.00	0.80	2.41	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	37.77	11.19	4.20	6.29	1.40	0.00	0.70	1.40	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	39.07	10.02	1.00	4.01	0.00	0.00	3.01	2.00	0.00
Cardiac Myocyte, donor1	11525-119I4	25.59	1.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	15.32	6.92	1.48	3.46	1.48	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	27.15	6.95	1.16	1.05	1.16	0.11	0.11	0.00	0.21
Chondrocyte - de diff, donor1	11261-116G1	26.00	9.36	2.77	6.59	2.77	0.35	0.69	0.00	0.35
Chondrocyte - de diff, donor2	11338-117F6	17.77	4.26	1.42	1.07	1.42	0.36	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	28.22	10.47	3.64	6.37	1.14	0.46	0.23	0.23	0.68
Chondrocyte - re diff, donor2	11339-117F7	46.55	8.06	4.48	1.79	0.90	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	27.90	6.47	1.21	2.83	1.62	0.81	0.00	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	55.66	10.33	4.36	3.44	2.64	1.15	0.11	0.92	1.03
Ciliary Epithelial Cells, donor2	11323-117D9	43.18	11.33	4.28	1.92	2.35	0.21	0.00	0.21	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	42.39	6.28	2.74	3.89	1.06	0.09	0.27	0.44	1.06
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	25.22	14.86	3.85	0.73	0.46	3.12	0.00	0.83	1.01
Corneal Epithelial Cells, donor1	11526-119I5	4.61	0.66	0.22	0.00	0.22	0.22	0.44	0.22	0.44
Corneal Epithelial Cells, donor2	11606-120I4	6.83	1.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	5.11	2.05	0.51	0.51	0.26	0.00	1.02	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	24.43	5.45	2.81	0.99	0.33	0.17	0.17	1.32	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	22.71	8.52	2.84	0.32	0.63	0.00	0.00	0.95	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	31.06	3.45	3.45	0.00	0.00	0.00	0.00	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	19.55	5.18	1.94	0.32	0.65	0.43	0.11	0.86	0.65
Dendritic Cells - plasmacytoid, donor1	11228-116C4	11.62	16.06	1.02	0.00	0.34	0.00	0.00	0.00	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	11.75	15.67	1.96	0.00	0.65	1.31	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	6.78	19.36	1.45	0.97	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	20.18	7.00	2.00	3.00	1.00	0.33	0.17	0.33	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	14.67	2.35	1.17	0.59	1.17	0.00	0.00	0.59	1.76
Endothelial Cells - Aortic, donor2	11340-117F8	15.84	4.52	0.28	0.57	0.85	0.28	0.28	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	21.23	2.36	1.18	0.79	0.79	0.79	0.00	0.79	0.00
Endothelial Cells - Artery, donor1	11264-116G4	15.13	3.78	0.87	0.29	0.29	0.58	0.29	0.00	0.29
Endothelial Cells - Artery, donor2	11341-117F9	16.47	6.82	0.71	1.88	1.18	0.47	0.00	0.00	0.47
Endothelial Cells - Artery, donor3	11413-118E9	15.78	6.84	1.93	2.63	0.35	0.53	0.00	0.18	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	36.79	7.09	2.88	3.99	0.89	0.22	0.00	0.66	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	44.73	6.39	3.96	4.87	1.83	0.91	0.30	0.30	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	46.23	5.64	2.54	3.95	1.97	0.56	0.00	0.56	1.13
Endothelial Cells - Microvascular, donor1	11265-116G5	20.50	4.75	2.38	1.78	1.19	0.30	0.00	0.30	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	27.60	2.60	3.12	3.12	1.56	0.00	0.00	2.08	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	17.44	4.25	0.85	1.42	0.43	0.28	0.43	0.14	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	26.01	13.20	5.60	7.60	3.20	1.20	0.00	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	16.25	5.24	0.00	1.57	0.52	0.00	0.00	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	56.53	15.41	2.36	2.98	3.11	1.12	0.12	0.99	0.62
Endothelial Cells - Umbilical vein, donor2	11324-117E1	28.68	5.87	1.09	2.39	0.65	0.22	0.00	1.30	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	32.36	6.35	1.83	1.47	1.22	1.34	0.00	0.24	0.85
Endothelial Cells - Vein, donor1	11267-116G7	9.10	5.69	0.00	3.41	1.14	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	18.86	2.79	1.40	3.49	0.70	0.70	0.00	2.10	0.00
Endothelial Cells - Vein, donor3	11416-118F3	22.45	5.18	1.26	1.73	1.73	0.00	0.00	0.16	0.00
Eosinophils, donor1	12244-129H3	45.74	15.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	21.45	6.60	0.00	1.65	4.95	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	10.70	3.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	5.13	0.49	0.98	0.98	0.24	0.49	0.49	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	8.32	2.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	29.15	7.80	1.64	2.05	1.64	0.00	0.00	0.00	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	15.88	5.04	1.75	1.97	1.09	0.44	0.11	0.11	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	26.00	7.26	1.84	3.79	1.52	0.33	0.65	0.11	0.65
Fibroblast - Aortic Adventitial, donor1	11245-116E3	33.35	7.64	1.82	2.18	1.46	0.24	0.00	0.24	0.49
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	24.56	8.19	3.28	2.05	1.09	2.59	0.41	0.27	1.23
Fibroblast - Aortic Adventitial, donor2	11326-117E3	23.20	7.38	1.90	3.38	1.27	0.63	0.11	0.84	0.95
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	10.80	6.59	0.79	1.05	0.53	0.26	0.00	0.53	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	19.60	8.97	2.66	4.65	1.99	0.66	0.00	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	23.13	4.99	0.45	1.36	0.91	0.00	0.91	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	10.61	3.03	2.27	0.76	0.00	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	11.83	5.52	1.26	1.42	0.79	0.16	0.00	0.16	0.16
Fibroblast - Cardiac, donor4	11452-119A3	30.01	11.82	2.42	3.03	1.82	0.30	0.30	0.00	0.61
Fibroblast - Cardiac, donor5	11456-119A7	28.55	7.23	2.16	1.52	1.27	0.00	0.00	0.25	0.51
Fibroblast - Cardiac, donor6	11460-119B2	22.89	6.82	1.67	1.06	0.61	0.15	0.15	0.30	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	13.13	5.76	0.94	1.07	1.07	0.40	0.00	0.13	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	12.51	4.31	0.43	2.59	0.43	0.86	0.00	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	30.76	11.72	0.00	0.00	1.46	0.00	0.00	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	22.83	5.30	1.85	2.08	1.85	0.00	0.00	0.46	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	36.30	6.78	1.87	2.04	1.19	0.34	1.19	0.00	0.34
Fibroblast - Dermal, donor1	11269-116G9	17.14	4.70	2.58	1.64	0.47	0.23	0.00	0.70	0.23
Fibroblast - Dermal, donor2	11346-117G5	15.57	5.19	2.83	0.47	0.94	0.00	0.00	0.47	0.47
Fibroblast - Dermal, donor3	11418-118F5	21.76	5.80	2.06	1.09	0.73	0.36	0.12	0.24	0.24
Fibroblast - Dermal, donor4	11450-119A1	28.60	4.86	3.05	2.15	1.13	0.68	0.11	0.11	0.45
Fibroblast - Dermal, donor5	11454-119A5	26.87	5.93	2.44	1.92	1.40	0.70	0.00	0.35	0.70
Fibroblast - Dermal, donor6	11458-119A9	26.64	8.28	3.41	2.60	0.16	0.65	0.00	0.00	0.97
Fibroblast - Gingival, donor1	11237-116D4	38.94	5.83	3.33	0.83	1.04	0.21	0.00	0.42	1.04
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	37.73	11.53	4.19	5.24	1.83	0.52	0.00	0.26	1.05
Fibroblast - Gingival, donor2	11318-117D4	31.23	7.25	2.11	0.66	0.79	0.53	0.00	0.00	0.79
Fibroblast - Gingival, donor3	11394-118C8	35.58	5.41	2.42	0.77	0.87	0.00	0.19	0.39	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	41.56	7.27	5.19	3.12	3.12	1.04	0.00	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	24.49	5.81	1.41	1.06	1.59	0.18	0.00	0.18	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	34.30	11.54	4.05	4.83	0.47	0.16	0.16	0.00	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	37.86	8.79	5.95	4.06	0.95	0.68	0.14	0.41	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	12.70	6.70	0.35	2.47	0.35	0.00	0.00	0.00	0.71
Fibroblast - Gingival, donor7 (control)	11924-125H7	39.34	10.68	3.51	3.66	1.61	0.58	0.15	0.44	1.61
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	45.27	9.95	3.82	2.59	2.45	0.27	0.27	0.82	0.82
Fibroblast - Gingival, donor8 (control)	11926-125H9	39.05	11.52	3.40	2.96	1.76	0.44	0.00	0.33	1.32
Fibroblast - Gingival, donor9 (control)	11927-125I1	48.57	8.22	2.20	2.20	1.76	0.59	0.29	0.73	0.73
Fibroblast - Lung, donor1	11270-116H1	10.87	2.72	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	32.83	7.46	4.48	1.49	1.49	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	13.08	4.22	0.63	0.63	0.63	0.21	0.00	0.21	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	10.83	3.33	0.83	0.83	1.67	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	15.38	6.99	1.40	1.40	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	3.36	2.52	0.00	0.56	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	23.95	6.90	4.87	1.62	0.81	0.81	0.00	0.41	1.22
Fibroblast - Mammary, donor2	11620-122A9	0.00	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	23.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	30.45	6.79	3.30	1.36	0.97	0.78	0.00	0.19	1.36
Fibroblast - Periodontal Ligament, donor2	11319-117D5	37.01	10.31	4.25	3.19	1.06	0.91	0.15	0.00	1.52
Fibroblast - Periodontal Ligament, donor3	11395-118C9	44.67	9.79	3.37	2.45	0.92	1.53	0.00	0.00	1.22
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	34.73	6.49	2.29	2.29	1.91	0.38	0.00	0.38	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	29.70	6.21	3.24	3.24	0.27	0.27	0.27	0.54	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	24.47	4.29	1.74	2.09	0.93	0.35	0.35	0.12	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	37.91	7.41	1.77	2.10	1.33	0.55	0.00	0.00	1.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	17.68	4.88	1.63	0.41	0.41	0.61	0.00	0.00	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	4.68	1.34	0.00	0.67	0.67	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	24.51	2.77	1.98	0.40	0.79	0.00	0.00	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	15.88	7.94	2.98	1.19	0.79	0.40	0.20	0.20	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	34.99	9.95	3.55	2.13	2.31	0.18	0.18	0.53	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	29.17	7.49	1.97	1.97	1.97	0.99	0.20	0.20	0.99
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	10.23	8.12	2.71	0.90	1.20	0.90	0.00	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	41.13	10.90	3.56	3.35	2.48	0.43	0.00	0.76	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	16.70	6.33	2.53	1.27	1.27	0.51	0.00	0.51	0.25
Fibroblast - skin normal, donor1	11553-120C5	33.64	9.02	2.63	2.79	1.80	0.66	0.33	0.49	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	23.06	6.02	2.81	0.80	1.40	0.80	0.00	0.00	0.60
Fibroblast - skin normal, donor2	11561-120D4	40.49	9.34	4.82	2.71	3.82	0.70	0.20	0.50	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	28.41	9.07	4.84	1.81	0.30	0.60	0.00	0.30	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	43.00	9.78	3.73	2.40	2.65	0.33	0.25	0.33	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	38.46	7.01	4.27	4.27	2.56	0.17	0.17	0.68	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	17.08	5.58	1.97	1.97	1.31	0.33	0.00	0.66	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	47.93	12.04	4.37	4.15	2.45	0.75	0.00	0.64	1.07
Fibroblast - skin walker warburg, donor1	11554-120C6	23.78	7.08	1.01	1.35	2.02	0.51	0.17	0.51	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	46.26	7.37	5.49	2.67	2.35	0.16	0.31	0.63	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	664.79	0.00	44.32	22.16	22.16	0.00	0.00	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	20.92	6.97	0.00	0.00	0.00	0.00	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	23.06	7.97	5.55	1.73	1.39	1.56	1.39	0.00	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	33.83	7.03	3.12	0.52	1.30	0.78	1.30	0.00	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	23.76	8.18	4.85	2.30	0.51	2.30	2.30	0.00	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	26.03	9.95	1.53	5.36	5.36	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	44.67	16.59	1.28	7.66	3.19	0.00	0.00	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	73.60	14.26	2.85	9.13	3.99	0.00	0.57	0.00	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	60.67	8.55	2.48	4.14	2.76	0.28	0.00	0.55	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	43.15	9.82	1.37	6.85	2.74	0.00	0.23	1.60	1.37
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	50.13	12.48	1.98	6.54	2.77	0.59	0.79	0.40	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	56.30	8.46	3.17	1.85	2.64	0.00	0.00	0.26	1.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	44.68	13.05	2.61	9.46	4.89	0.00	0.00	1.30	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	70.31	10.61	1.33	7.08	4.86	0.00	0.44	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	35.75	5.51	1.41	3.67	2.54	0.42	0.42	0.00	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	35.59	7.76	1.35	3.69	1.48	0.25	0.37	0.25	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	35.19	4.30	1.61	2.95	2.15	0.27	0.00	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	45.84	5.82	1.24	2.85	2.11	0.00	0.12	0.37	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	47.48	5.95	1.52	3.05	1.52	0.14	0.14	0.14	0.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	31.92	3.46	1.02	2.03	2.85	0.00	0.41	0.20	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	47.00	7.30	1.60	2.74	2.74	0.46	0.23	0.00	1.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	48.46	6.23	2.37	3.11	1.99	0.25	0.00	0.37	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	35.63	3.28	2.62	2.40	1.75	0.22	0.00	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	33.98	2.95	0.59	2.66	2.07	0.00	0.30	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	40.69	6.52	0.95	4.45	1.75	0.32	0.00	0.32	0.95
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	37.31	6.70	2.68	3.35	0.89	0.22	0.45	0.45	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	37.71	6.45	0.81	1.61	1.81	0.20	0.00	0.40	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	39.19	8.65	1.19	3.22	1.70	0.00	0.17	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	41.41	9.13	1.42	3.01	3.28	0.09	0.09	0.53	0.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	38.71	7.60	2.81	2.19	3.64	0.42	0.21	0.31	0.73
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	39.96	7.86	0.68	1.54	1.71	0.00	0.00	0.51	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	33.42	5.42	1.00	2.32	1.55	0.22	0.00	0.11	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	41.35	8.15	2.50	2.41	2.08	0.42	0.17	0.42	0.58
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	31.24	6.74	1.63	2.25	2.04	0.00	0.41	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	35.69	4.33	1.03	2.27	1.03	0.00	0.21	0.00	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	37.36	5.07	1.04	3.00	0.92	0.35	0.00	0.35	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	30.52	6.67	2.33	2.33	1.83	0.00	0.00	0.17	0.50
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	34.39	5.73	0.66	2.42	1.98	0.00	0.00	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	34.44	5.04	1.35	3.69	0.61	0.00	0.00	0.25	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	27.23	6.00	0.97	1.78	1.95	0.00	0.16	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	33.68	7.06	0.96	1.60	2.57	0.32	0.32	0.00	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	28.43	5.12	1.52	1.99	1.04	0.19	0.09	0.28	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	28.79	4.59	1.42	2.06	0.47	0.32	0.32	0.16	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	31.02	6.08	1.52	0.61	0.61	0.30	0.00	0.30	1.82
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	27.39	5.75	1.46	1.25	0.94	0.00	0.10	0.10	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	27.88	6.37	0.88	1.98	1.10	0.22	0.22	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	27.49	5.61	0.28	2.52	0.56	0.00	0.00	0.00	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	21.57	4.54	1.11	1.48	1.02	0.00	0.00	0.28	0.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	29.15	5.62	1.07	1.07	1.60	0.27	0.27	0.27	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	28.15	6.43	2.60	1.38	1.22	0.15	0.00	0.46	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	27.72	5.96	0.91	1.17	1.68	0.13	0.26	0.00	0.65
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	26.84	4.61	2.44	1.36	1.63	0.00	0.27	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	27.47	6.45	1.47	1.66	2.21	0.18	0.00	0.18	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	24.78	4.17	1.97	1.32	0.66	0.22	0.00	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	37.69	1.98	1.98	2.98	1.98	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	23.61	5.41	1.19	2.51	0.92	0.13	0.13	0.13	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	19.37	4.64	0.61	0.81	1.41	0.00	0.00	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	28.21	5.59	2.29	2.03	2.29	0.00	0.25	0.00	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	35.63	9.55	1.59	5.77	4.18	0.00	0.40	0.00	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	32.20	5.70	1.23	4.01	0.62	0.15	0.15	0.15	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	42.96	9.62	1.43	4.09	1.23	0.00	0.20	0.20	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	52.57	9.70	2.19	12.83	4.38	0.63	0.31	0.00	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	48.88	5.65	2.54	7.06	3.39	0.00	0.57	0.28	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	40.12	6.46	2.77	9.69	1.84	0.00	0.46	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	54.45	24.75	0.00	29.70	4.95	0.00	0.00	2.47	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	58.02	12.76	2.71	17.41	4.64	0.39	1.16	0.39	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	72.20	17.65	1.60	19.25	4.81	1.60	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	48.69	5.22	0.00	12.17	3.48	1.74	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	55.01	14.97	2.60	18.23	5.53	0.33	0.98	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	59.30	16.88	2.06	19.35	4.94	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	39.99	10.00	3.33	13.33	6.66	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	60.12	19.58	4.75	16.22	4.47	0.28	0.00	0.00	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	58.18	14.38	2.61	18.63	4.25	0.65	0.00	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	47.81	8.39	0.00	10.90	1.68	0.00	0.84	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	70.93	18.13	6.04	11.45	5.73	0.64	0.64	0.64	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	51.63	13.25	4.76	11.89	4.08	0.34	0.34	0.34	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	56.38	14.62	0.00	10.44	4.18	4.18	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	56.70	13.17	5.73	9.16	3.44	0.00	0.00	0.00	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	43.81	11.25	0.89	5.92	4.44	0.30	0.00	0.30	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	50.82	15.25	0.00	8.47	5.08	1.69	0.00	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	58.82	15.33	5.80	9.94	3.73	0.41	0.41	0.83	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	58.45	13.81	2.99	8.51	3.22	0.46	0.69	0.92	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	63.22	5.27	10.54	15.81	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	53.05	13.84	1.92	10.38	6.15	0.38	0.00	0.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	56.39	17.28	1.63	11.41	4.89	0.65	0.65	0.33	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	84.94	13.38	4.01	18.73	4.68	0.67	0.67	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	77.05	13.48	2.70	7.71	4.62	0.00	0.00	0.39	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	44.50	23.96	3.08	10.27	3.08	0.68	0.34	0.68	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	47.21	19.88	2.48	9.94	2.48	0.00	0.00	2.48	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	79.27	11.80	4.25	12.27	3.77	0.00	0.00	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	74.23	10.86	3.62	11.47	2.41	0.00	0.00	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	70.20	15.77	4.58	17.29	5.09	0.51	0.00	0.51	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	78.17	10.37	2.39	13.16	3.99	0.40	0.80	0.40	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	80.42	13.32	1.97	12.33	2.96	0.00	0.49	0.99	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	49.58	7.08	1.18	11.80	4.72	0.00	1.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	57.18	12.84	4.08	8.17	6.42	0.00	0.00	1.75	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	57.05	9.22	5.71	12.73	6.14	0.44	0.88	1.32	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	53.40	5.93	2.54	4.24	0.85	0.85	0.85	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	36.41	8.95	1.79	5.97	1.79	1.19	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	44.64	8.25	1.94	9.70	5.82	0.00	0.00	0.97	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	15.98	5.71	2.28	2.28	0.00	2.28	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	12.06	3.33	2.08	0.83	2.08	0.00	0.00	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	19.12	7.87	4.50	1.12	1.12	0.00	0.00	1.12	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	23.15	3.81	3.81	5.07	0.95	0.32	0.95	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	16.71	3.34	2.09	2.92	2.09	0.00	0.00	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	14.16	5.34	2.32	0.58	0.70	0.58	0.12	0.12	0.58
Hep-2 cells mock treated, biol_rep2	11899-125E9	10.80	4.56	0.84	0.17	0.51	0.34	0.17	0.00	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	13.20	4.32	1.14	0.46	0.91	0.68	0.23	0.46	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	10.49	4.70	1.53	0.55	0.55	0.22	0.33	0.11	0.77
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	10.75	6.66	1.29	0.64	1.07	0.43	0.21	0.00	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	14.21	6.67	1.08	0.22	0.43	0.00	0.00	0.43	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	9.22	4.61	1.49	0.25	0.37	0.12	0.12	0.37	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	8.06	4.12	0.86	0.17	0.34	0.51	0.00	0.17	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	10.57	2.56	1.28	0.32	1.28	0.32	0.00	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	15.11	2.80	2.24	2.24	0.56	0.00	0.00	0.56	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	4.76	1.30	0.87	0.87	0.87	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	37.01	13.22	2.64	7.93	5.29	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	11.99	3.17	2.12	1.76	1.41	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	7.27	5.09	0.00	0.00	1.45	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	27.80	6.82	2.62	3.32	0.70	0.00	0.00	0.00	0.70
Hepatocyte, donor1	11523-119I2	25.42	20.58	0.00	3.63	1.21	0.00	0.00	0.00	1.21
Hepatocyte, donor2	11603-120I1	19.39	17.24	0.00	0.00	1.08	1.08	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	17.18	14.11	0.61	1.23	0.61	0.00	0.00	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	28.72	11.75	1.31	1.31	0.65	1.31	0.00	1.31	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	54.53	14.68	1.40	2.45	2.45	0.00	0.00	0.17	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	38.97	6.59	3.57	1.92	1.51	0.27	0.14	0.41	1.51
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	3.18	12.74	0.00	3.18	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	20.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	1.38	6.92	1.38	0.00	0.00	4.15	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	5.01	2.50	0.00	0.00	2.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	23.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	0.00	5.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	4.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	8.12	14.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	5.00	6.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	10.89	0.00	0.00	0.00	0.00	0.00	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	1.32	6.62	1.32	0.00	0.00	2.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	1.11	8.87	2.22	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	5.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	4.41	12.60	0.00	2.52	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	6.19	13.92	1.55	0.00	0.00	1.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	14.63	0.00	0.00	0.00	0.00	0.00	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	1.29	17.44	0.65	2.58	0.00	0.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	4.83	12.88	1.61	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	4.89	11.41	1.63	0.81	0.81	0.00	0.00	0.00	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	2.10	10.08	0.84	0.42	0.00	0.84	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	7.23	15.27	1.61	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	4.62	5.54	0.00	0.92	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	15.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	4.25	6.14	0.94	0.00	0.00	1.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	4.53	4.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	6.46	9.69	1.08	1.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	5.08	3.81	1.27	0.00	0.00	3.81	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	16.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	11.48	7.65	0.00	0.00	0.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	7.29	7.29	1.82	1.82	0.00	0.00	0.00	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	4.28	8.57	0.71	0.00	0.00	0.71	0.00	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	16.59	0.00	0.00	6.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	5.86	8.03	1.23	0.93	0.31	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	5.27	8.78	1.76	3.51	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	3.14	9.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	5.56	8.34	1.39	0.70	0.00	0.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	13.28	6.64	0.00	2.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	22.69	6.48	0.00	3.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	9.59	4.36	0.00	2.62	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	4.50	4.50	2.25	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	6.97	10.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	7.47	9.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	8.31	6.93	0.00	1.39	0.00	2.77	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	6.44	8.28	0.00	0.92	0.00	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	3.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	0.00	0.00	6.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	5.29	7.40	1.06	1.06	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	14.85	4.49	1.39	1.22	0.57	0.90	0.90	0.00	0.41
Keratinocyte - epidermal, donor2	11349-117G8	11.13	4.69	2.34	0.00	0.00	0.00	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	27.83	8.14	1.89	0.85	0.57	0.76	2.08	0.09	0.76
Keratinocyte - oral, donor1	11251-116E9	44.39	6.92	5.22	5.22	1.70	0.23	3.63	0.45	1.14
Keratocytes, donor1	11527-119I6	18.91	3.78	2.41	1.72	0.69	0.00	0.00	0.34	0.00
Keratocytes, donor2	11607-120I5	10.55	2.34	0.00	1.17	0.00	1.17	0.00	0.00	1.17
Keratocytes, donor3	11688-122I5	28.26	5.14	2.17	1.38	1.58	0.00	0.20	0.20	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	15.39	10.99	0.00	0.00	2.20	2.20	0.00	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	29.13	6.47	2.16	5.39	0.00	1.08	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	56.17	6.57	2.19	2.54	3.11	0.00	0.00	0.00	1.27
Lens Epithelial Cells, donor3	11690-122I7	53.38	6.76	5.35	4.44	2.62	0.30	0.61	1.11	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	27.75	6.40	2.25	2.02	1.54	0.36	0.00	0.12	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	13.95	5.86	1.40	0.56	0.28	0.00	0.00	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	28.96	8.03	3.62	1.10	0.63	0.63	0.00	0.16	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	14.52	2.15	1.61	1.61	1.08	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	15.76	5.36	1.58	0.32	0.32	0.32	0.00	0.00	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	13.91	4.53	0.75	1.29	0.43	0.32	0.00	0.22	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	26.68	6.16	1.23	0.82	1.64	0.41	0.00	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	10.37	2.78	0.00	0.76	0.25	0.25	0.00	0.00	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	16.05	6.33	1.41	1.69	0.42	0.56	0.14	0.00	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	18.19	3.56	0.79	1.58	0.79	0.40	0.00	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	18.81	6.20	1.36	0.97	0.39	0.19	0.00	0.00	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	7.22	3.15	1.30	0.74	0.19	0.19	0.00	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	22.65	5.57	0.00	1.05	0.00	0.35	0.00	0.00	1.05
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	16.94	5.01	1.19	1.19	0.95	0.24	0.00	0.00	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	16.89	4.94	0.82	0.82	0.27	0.27	0.00	0.14	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	18.48	5.85	0.92	0.62	0.92	0.00	0.00	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	9.66	4.68	0.31	0.31	0.31	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	11.16	4.39	0.37	0.73	0.55	0.18	0.00	0.18	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	22.71	5.92	0.99	1.32	0.66	0.33	0.00	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	8.79	4.10	0.29	1.17	0.59	0.00	0.00	0.29	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	7.22	3.49	0.50	0.25	0.50	0.50	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	19.88	2.91	2.42	0.97	0.48	0.48	0.00	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	15.89	3.50	1.08	0.81	0.54	0.00	0.00	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	13.02	3.94	0.61	0.61	0.45	0.00	0.00	0.30	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	16.07	2.59	0.52	1.56	0.00	0.00	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	16.75	6.07	0.63	1.47	0.21	0.42	0.00	0.21	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	13.68	4.51	0.60	0.60	0.15	0.60	0.00	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	11.01	2.75	0.00	0.69	0.00	0.00	0.00	0.69	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	15.99	4.70	1.51	0.94	0.00	0.38	0.00	0.38	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	13.57	3.18	0.21	1.06	0.21	0.21	0.00	0.00	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	20.35	4.85	1.45	2.91	0.48	0.00	0.00	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	8.93	3.64	0.33	0.00	0.33	0.33	0.00	0.33	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	11.15	3.35	0.87	0.50	0.00	0.12	0.00	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	32.21	6.66	1.11	2.22	0.37	0.37	0.00	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	15.57	2.72	0.74	0.49	0.25	0.00	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	9.07	4.40	0.55	0.27	0.55	0.41	0.14	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	27.34	5.79	1.61	1.93	0.64	0.32	0.00	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	18.56	6.70	1.52	0.61	0.91	0.00	0.00	0.30	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	25.47	7.42	1.40	1.54	0.70	0.14	0.00	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	22.76	8.18	1.78	0.71	1.07	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	7.76	0.97	0.00	0.48	1.45	0.00	0.00	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	8.40	2.18	0.16	0.31	0.16	0.47	0.00	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	20.41	6.09	0.72	0.72	0.72	0.00	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	11.43	2.61	1.31	0.98	0.00	0.00	0.00	0.00	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	7.77	2.35	0.24	0.24	0.24	0.24	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	28.46	4.83	1.11	1.24	1.61	0.50	0.00	0.25	0.50
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	10.76	3.07	1.28	0.77	0.00	0.00	0.00	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	9.55	4.18	0.30	0.90	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	27.19	20.39	0.00	2.27	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	22.25	6.14	2.30	5.37	0.00	0.00	0.00	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	21.52	7.42	1.48	2.23	0.00	1.48	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	18.19	9.73	1.69	1.27	0.00	0.42	0.00	0.00	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	13.36	7.74	1.41	1.41	0.70	0.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	18.68	4.67	2.80	0.00	0.93	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	16.49	6.70	0.52	0.52	2.06	0.52	0.52	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	10.71	5.95	1.19	1.19	1.19	2.38	0.00	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	19.90	5.20	2.04	1.36	0.90	0.68	0.23	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	19.19	8.72	2.91	0.87	0.87	0.29	0.29	0.29	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	21.61	8.10	4.05	0.00	1.35	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	20.86	7.45	3.12	2.30	1.08	0.54	0.00	0.41	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	17.46	5.14	1.54	3.08	1.03	0.00	0.00	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	18.35	6.35	2.82	1.41	1.06	0.35	0.00	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	16.66	7.33	2.00	0.67	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	19.36	5.60	2.04	1.02	1.02	1.53	0.51	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	21.61	8.27	2.93	3.20	0.53	0.53	0.00	0.00	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	22.30	6.24	1.70	2.27	1.13	0.57	0.00	0.38	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	22.09	4.91	1.84	3.07	0.61	0.61	0.00	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	18.75	12.23	3.26	0.82	0.82	2.45	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	21.87	8.33	1.67	2.08	0.62	0.62	0.00	0.42	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	26.06	7.57	1.68	3.36	0.84	0.28	0.00	0.56	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	12.36	7.21	2.06	1.03	2.06	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	21.19	7.26	1.16	1.16	0.58	0.00	0.00	0.29	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	14.65	9.86	1.79	2.69	0.60	0.30	0.00	0.30	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	21.58	6.09	2.77	1.11	1.11	0.55	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	17.67	9.19	2.83	3.18	1.06	1.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	14.75	5.16	3.69	1.48	1.48	0.74	0.37	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	16.12	4.61	1.15	3.45	1.15	1.15	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	14.97	3.84	0.77	1.54	0.38	0.38	0.00	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	22.08	7.36	1.70	1.70	0.57	0.00	1.13	0.57	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	15.59	9.85	0.82	0.00	0.82	1.64	0.00	0.00	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	16.27	7.23	1.36	1.81	0.90	0.45	0.45	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	22.26	8.62	2.15	0.72	0.72	2.15	0.72	0.00	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	21.66	5.98	0.75	0.75	1.49	0.75	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	18.95	9.29	1.49	2.60	0.00	1.49	0.00	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	16.80	3.88	2.15	2.58	1.72	0.86	0.43	1.29	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	23.98	4.28	2.57	1.71	0.00	0.86	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	18.66	5.00	1.00	2.00	0.33	0.67	0.00	1.00	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	13.88	7.84	2.41	0.60	0.60	0.00	0.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	12.09	4.98	1.42	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	20.97	5.16	0.69	1.37	0.34	0.34	0.00	0.34	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	16.10	9.12	0.54	1.61	0.00	0.54	0.54	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	15.49	4.04	0.00	0.67	1.35	0.00	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	14.82	4.07	0.37	0.37	0.74	0.37	0.00	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	24.42	8.14	2.33	2.33	2.33	1.16	0.00	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	15.87	4.23	2.12	1.06	1.06	0.00	0.00	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	18.41	7.20	1.20	0.40	1.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	15.26	8.00	2.18	0.73	0.73	0.00	0.73	0.73	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	30.66	7.67	3.07	0.77	0.77	0.77	0.00	0.77	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	17.76	5.92	2.96	0.49	0.99	0.49	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	16.00	7.53	1.88	2.82	0.00	0.00	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	21.12	7.54	3.52	3.02	0.50	0.00	0.50	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	18.48	7.66	3.15	1.35	0.45	0.45	0.00	1.35	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	12.05	12.05	1.72	5.16	1.72	3.44	0.00	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	18.70	8.91	1.78	2.67	0.45	0.45	0.00	0.00	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	18.77	5.47	4.30	1.96	1.56	0.78	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	11.22	3.30	1.98	2.64	0.66	0.66	0.00	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	19.72	7.26	3.63	2.59	1.04	0.52	0.00	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	17.07	9.19	2.63	1.31	0.44	0.00	0.00	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	15.65	8.39	3.35	2.80	0.56	1.12	1.12	0.00	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	13.69	6.62	3.53	0.88	0.88	0.88	0.00	0.44	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	16.20	5.79	2.70	0.77	1.16	0.39	0.00	0.77	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	19.24	3.54	2.53	0.51	0.51	1.52	0.51	1.01	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	14.90	7.21	2.40	0.96	0.00	0.48	0.00	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	22.26	7.16	1.19	1.99	0.40	0.80	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	11.54	6.08	3.65	0.61	0.61	0.00	0.61	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	11.76	6.23	2.08	0.00	0.69	0.69	0.00	1.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	19.38	8.36	1.90	1.14	0.38	0.00	0.38	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	15.49	9.81	1.55	1.03	0.00	0.00	0.52	0.00	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	11.49	10.88	1.81	1.21	0.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	12.99	6.97	1.90	0.95	1.27	0.63	0.00	0.32	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	18.13	4.26	1.60	2.13	0.00	0.00	0.00	1.07	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	9.19	7.47	2.87	1.15	0.57	1.15	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	18.00	3.60	1.03	1.03	0.00	1.54	0.51	1.03	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	15.56	4.24	1.41	1.41	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	13.05	7.94	2.84	1.70	0.00	0.00	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	15.81	5.41	1.25	1.25	0.00	0.42	0.42	1.25	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	14.88	6.26	2.35	2.35	0.00	0.78	0.00	0.78	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	8.77	6.26	1.25	0.84	0.00	0.00	0.00	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	18.12	6.50	1.86	0.93	0.93	0.46	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	14.72	8.03	2.01	0.67	0.00	0.67	0.00	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	14.44	4.81	1.60	3.74	0.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	24.65	4.85	3.64	1.62	0.81	1.62	0.00	0.40	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	12.85	4.59	3.67	0.92	0.00	1.84	0.00	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	13.34	4.45	7.11	0.00	0.00	0.89	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	18.24	6.84	3.99	0.00	2.85	1.71	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	22.24	6.90	3.07	1.53	1.53	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	16.42	4.38	2.19	1.09	1.09	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	17.82	7.57	3.12	1.78	0.45	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	18.46	8.84	2.08	2.60	0.52	0.78	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	15.25	9.28	3.98	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	18.71	2.08	2.08	2.08	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	19.14	3.65	1.14	0.68	2.05	0.23	0.23	0.91	0.46
Macrophage - monocyte derived, donor2	11313-117C8	19.64	4.95	2.20	0.37	0.18	0.00	0.37	0.92	0.37
Macrophage - monocyte derived, donor3	11389-118C3	19.66	4.72	1.70	0.13	0.26	0.00	0.00	0.52	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	31.86	9.56	5.84	1.06	0.00	2.12	1.06	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	50.86	11.25	3.64	2.54	3.01	1.90	1.58	0.32	0.79
Mallassez-derived cells, donor3	11930-125I4	43.23	8.90	5.56	1.53	1.81	1.67	2.22	0.28	0.69
Mammary Epithelial Cell, donor1	11273-116H4	64.27	12.26	3.29	2.39	2.09	1.30	8.57	0.80	0.90
Mammary Epithelial Cell, donor2	11350-117G9	32.72	9.84	4.05	2.03	2.90	0.58	5.21	0.29	0.87
Mammary Epithelial Cell, donor3	11422-118F9	8.73	4.49	1.25	0.00	0.25	0.50	1.00	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	103.72	18.98	8.81	0.68	2.71	0.68	0.68	1.36	0.68
Mast cell, donor1	11563-120D6	41.96	7.14	2.38	1.08	0.87	0.00	0.22	0.97	0.97
Mast cell, donor2	11565-120D8	39.23	7.13	1.49	0.89	0.89	0.00	0.00	0.89	0.89
Mast cell, donor3	11566-120D9	43.00	13.06	4.95	1.13	0.23	0.23	0.23	0.45	0.90
Mast cell, donor4	11567-120E1	35.28	7.80	4.08	1.42	0.53	0.00	0.00	0.53	1.06
Mast cell, expanded and stimulated, donor5	11940-126A5	50.79	10.42	3.44	0.78	1.33	0.22	0.22	0.89	2.00
Mast cell, expanded and stimulated, donor8	11942-126A7	36.77	10.51	1.75	1.75	0.58	0.00	1.17	0.58	1.17
Mast cell, expanded, donor5	11939-126A4	41.99	8.72	2.75	0.34	1.03	0.34	0.34	0.57	0.92
Mast cell, expanded, donor8	11941-126A6	28.12	7.20	1.51	0.67	0.33	0.33	0.00	0.17	0.17
Melanocyte - dark, donor1	11502-119F8	41.29	7.26	1.69	1.69	1.89	0.40	0.20	0.50	0.70
Melanocyte - dark, donor2	11582-120F7	22.50	7.27	2.42	1.73	0.69	0.35	0.00	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	42.23	3.84	2.68	1.45	1.81	0.14	0.00	0.22	0.87
Melanocyte - light, donor1	11274-116H5	10.11	1.18	0.47	0.71	0.47	0.71	0.00	0.47	0.24
Melanocyte - light, donor2	11351-117H1	8.19	2.05	0.00	1.36	0.00	0.00	0.00	0.00	0.68
Melanocyte - light, donor3	11423-118G1	7.81	1.73	0.00	0.87	0.87	0.00	0.87	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	26.55	3.33	1.15	1.67	0.52	0.21	0.00	0.52	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	27.43	4.30	2.96	2.42	1.08	0.54	0.27	0.54	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	34.55	4.82	2.41	2.14	0.80	0.27	0.00	0.54	0.27
Meningeal Cells, donor1	11493-119E8	22.95	6.08	1.12	1.24	0.87	0.37	0.00	0.00	0.37
Meningeal Cells, donor2	11573-120E7	20.69	3.96	1.76	1.76	0.00	1.32	0.00	0.00	0.44
Meningeal Cells, donor3	11654-122E7	42.87	8.97	2.20	1.47	1.22	0.73	0.00	0.16	1.22
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	49.33	7.98	4.56	4.28	2.28	0.29	0.57	0.57	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	29.99	7.04	2.92	2.62	1.81	0.81	0.40	0.40	0.60
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	6.57	2.63	1.31	2.63	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	6.54	1.31	0.00	0.00	1.31	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	13.63	5.74	0.72	0.00	1.44	0.00	0.00	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	29.22	4.45	3.60	2.12	1.06	0.42	0.21	0.00	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	24.13	4.02	1.01	1.51	1.01	0.00	0.00	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	14.28	2.64	0.44	1.32	1.10	0.88	0.44	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	11.69	4.38	0.00	2.19	1.46	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	7.98	1.64	0.82	1.02	1.02	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	35.18	5.12	4.29	5.40	1.66	0.00	0.42	0.28	0.97
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	4.83	0.00	0.00	0.00	0.37	0.00	0.00	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	21.05	4.87	1.45	0.53	0.79	0.53	0.26	0.39	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	4.45	1.78	0.89	0.30	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	15.37	4.48	1.28	1.28	0.64	0.64	0.64	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	31.19	7.80	2.13	0.00	0.71	0.71	0.00	0.35	1.06
Mesenchymal stem cells - hepatic, donor0	11218-116B3	17.20	4.38	0.94	0.00	0.94	0.00	0.31	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	21.77	3.63	1.45	3.63	2.18	0.00	0.00	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	32.62	12.20	5.83	2.92	1.59	0.27	0.27	0.00	0.53
Mesothelial Cells, donor2	12156-128G5	24.52	11.01	3.00	2.00	1.00	0.00	0.00	0.50	0.50
Mesothelial Cells, donor3	11402-118D7	20.74	8.82	2.10	0.94	0.51	0.79	0.07	0.22	0.58
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	6.75	4.05	0.00	0.00	0.00	0.00	0.00	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	16.25	5.91	1.23	0.74	0.49	0.00	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	15.02	6.77	1.47	0.59	0.59	0.29	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	3.46	0.00	0.00	0.00	0.00	0.00	0.00	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	10.54	7.44	0.62	0.62	0.62	0.31	0.00	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	13.28	3.53	3.11	1.66	0.62	0.41	0.00	0.41	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	15.77	6.51	1.25	0.00	0.75	0.00	0.25	0.50	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	17.69	6.52	0.47	0.93	0.00	0.00	0.00	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	17.07	4.67	1.83	0.41	0.20	0.20	0.00	0.61	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	14.65	2.77	0.79	0.40	0.00	0.40	0.00	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	11.50	4.42	1.77	0.00	0.88	0.00	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	17.86	4.18	2.28	0.38	0.76	0.00	0.00	1.14	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	0.00	1.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	13.58	5.31	1.70	0.42	0.00	0.00	0.42	0.64	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	9.21	4.60	0.92	0.00	0.00	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	8.94	2.68	1.79	0.00	0.00	0.00	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	3.35	3.35	0.00	1.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	13.80	3.76	0.75	0.25	0.25	0.00	0.50	0.75	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	12.83	4.28	2.38	0.71	0.71	0.71	0.00	0.48	0.95
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	1.66	3.32	0.55	0.00	0.00	0.00	0.00	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	9.21	5.07	0.92	0.00	0.46	0.00	0.69	0.23	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	12.83	5.26	2.52	0.63	0.63	0.21	0.00	0.84	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	12.43	3.47	0.41	0.20	0.20	0.41	0.20	0.20	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	13.95	4.93	1.07	0.64	0.21	0.00	0.21	0.86	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	9.78	4.00	2.00	0.44	0.89	0.22	0.44	0.44	0.89
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	8.98	3.29	0.66	0.44	0.00	0.22	0.00	0.44	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	6.59	2.03	0.51	0.51	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	8.28	1.66	1.66	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	8.97	2.99	0.54	0.00	0.27	0.00	0.00	0.82	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	10.29	3.53	1.18	1.18	0.29	0.59	0.00	0.29	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	1.09	1.09	0.00	0.00	0.00	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	8.65	5.29	0.48	0.48	0.00	0.48	0.48	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	10.81	4.80	1.20	0.00	0.40	0.00	0.00	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	4.11	1.37	0.00	0.00	0.00	0.00	1.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	10.01	5.51	0.50	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	4.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	9.20	5.26	2.63	0.44	0.44	0.00	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	3.31	3.31	0.00	0.00	0.00	0.00	0.00	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	5.76	1.92	0.64	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	13.88	5.21	0.99	0.25	0.99	0.00	0.25	0.99	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	5.57	3.48	0.70	0.70	0.00	0.00	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	13.26	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	10.94	5.47	3.08	0.34	0.34	0.34	0.34	0.68	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	6.13	3.94	1.31	0.00	0.00	0.44	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	5.68	3.55	0.00	0.36	0.00	0.00	0.00	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	18.80	8.70	1.96	0.00	0.28	0.84	0.00	0.28	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	11.22	3.33	1.66	0.42	0.00	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	7.58	2.91	0.58	0.00	0.58	0.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	14.78	6.03	0.60	0.30	0.00	0.00	0.00	0.30	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	14.61	5.01	2.50	0.00	0.42	0.83	0.00	1.67	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	14.78	6.46	0.92	1.85	0.92	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	11.38	3.98	1.71	0.57	0.57	0.00	0.00	1.14	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	12.99	4.56	1.38	0.14	0.14	0.41	0.28	0.14	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	18.14	5.44	0.52	0.26	0.26	0.26	0.00	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	13.73	6.01	1.72	0.43	0.00	0.00	0.00	1.29	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.26	5.08	0.00	0.00	0.64	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	13.61	3.47	0.80	0.80	0.53	0.27	0.00	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	13.47	5.69	1.50	0.90	0.00	0.00	0.00	1.20	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	11.58	3.81	1.55	0.28	0.14	0.00	0.00	0.42	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	16.56	7.01	2.23	0.64	0.00	0.32	0.00	0.00	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	20.34	5.09	1.99	1.11	1.55	0.00	0.00	1.77	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	12.13	4.17	0.76	0.00	0.38	0.00	0.00	0.00	1.52
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	15.91	6.82	2.27	1.42	0.57	0.00	0.00	0.57	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	18.93	7.87	2.46	1.72	0.98	0.00	0.25	0.74	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	10.43	3.26	0.65	0.65	0.00	0.65	0.00	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	16.17	4.41	1.76	0.59	0.59	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	16.43	4.61	3.17	0.00	0.86	0.29	0.58	0.86	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	21.43	6.59	0.41	0.00	0.00	0.82	0.00	0.41	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	15.48	4.47	1.49	0.30	0.00	0.00	0.00	0.89	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	7.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	24.95	5.35	1.78	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	18.07	7.23	1.97	0.66	0.66	0.00	0.33	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	12.62	5.26	0.00	0.00	3.16	0.00	0.00	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	17.40	7.31	1.78	0.79	0.99	0.00	0.00	0.20	0.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	13.97	5.59	1.86	0.93	0.00	0.00	0.00	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	19.53	6.76	1.13	0.38	0.38	0.00	0.38	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	14.65	4.79	1.33	0.27	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	17.19	5.54	1.13	0.11	0.23	0.00	0.00	0.11	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	4.42	3.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	16.12	8.43	0.00	1.83	0.00	0.00	0.00	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	18.67	9.33	3.11	0.00	0.00	0.00	1.56	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	25.65	9.09	1.60	0.00	0.53	0.00	0.00	0.53	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	19.32	7.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	6.06	7.07	1.01	0.00	0.00	1.01	0.00	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	15.60	3.37	1.69	0.00	0.84	0.00	0.00	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	24.51	8.17	1.36	0.00	1.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	21.62	4.45	1.27	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	38.06	8.91	4.05	0.81	0.00	0.00	0.81	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	10.57	6.04	3.02	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	62.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	32.62	32.62	0.00	3.26	0.00	0.00	3.26	6.52	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	12.55	12.55	25.10	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	25.64	9.05	2.80	1.72	1.29	0.43	0.00	0.22	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	38.15	7.32	0.52	3.66	0.52	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	18.69	2.00	0.67	0.67	0.00	0.00	0.00	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	10.43	1.67	0.42	0.83	0.00	0.83	0.00	0.00	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	38.03	7.61	1.33	3.04	3.42	0.38	0.38	0.57	0.95
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	39.90	7.98	1.60	7.98	0.00	0.00	0.00	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	7.48	1.36	0.00	0.68	0.68	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	97.39	1.84	7.35	7.35	7.35	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	18.83	3.35	0.84	1.26	1.26	0.42	0.00	0.00	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	22.78	3.95	0.70	1.16	1.63	0.23	0.00	0.93	0.70
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	20.81	2.70	0.54	1.89	1.08	0.00	0.00	0.00	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	20.39	5.68	1.26	1.68	1.47	0.00	0.21	0.21	0.84
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	89.08	11.13	11.13	0.00	22.27	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	20.35	1.49	2.48	3.47	2.48	0.50	0.00	0.50	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	26.25	4.33	3.25	3.25	0.54	0.00	0.54	0.27	1.08
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	25.39	3.63	1.81	2.95	1.13	0.00	0.23	0.68	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	16.98	3.10	0.65	1.80	0.98	0.33	0.16	0.65	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	21.69	4.19	2.37	2.73	1.64	0.00	0.36	0.18	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	15.91	3.18	1.59	3.71	1.06	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	13.21	4.20	0.00	4.20	0.00	0.00	0.00	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	52.84	7.22	2.30	5.58	1.31	0.33	0.33	0.98	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	20.49	3.90	1.30	1.79	1.14	0.00	0.33	0.65	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	24.16	5.64	2.82	2.82	0.71	0.18	0.88	1.06	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	15.47	5.63	1.41	4.92	1.41	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	18.39	1.38	0.46	1.38	0.46	0.00	0.46	1.84	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	23.14	3.86	2.25	1.29	1.29	0.00	0.32	1.29	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	39.66	8.28	3.10	4.14	2.76	0.00	0.69	1.03	1.72
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	85.97	5.06	7.59	17.70	5.06	0.00	0.00	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	19.38	5.35	2.01	2.45	1.11	0.00	0.00	1.56	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	21.17	1.27	0.42	1.27	0.42	0.00	0.00	2.12	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	20.65	3.56	1.90	3.32	1.42	0.00	0.47	0.71	0.71
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	27.90	5.58	1.29	1.72	2.58	0.00	0.00	2.58	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	180.56	9.03	0.00	0.00	9.03	0.00	0.00	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	20.33	4.33	1.00	3.00	1.33	0.33	0.00	1.33	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	16.23	1.80	0.90	1.80	1.80	0.45	0.45	1.35	1.80
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	30.16	4.36	1.98	1.19	0.00	0.40	0.40	1.98	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	17.64	0.93	0.00	0.93	0.93	0.00	0.00	0.93	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	35.19	2.65	1.14	3.03	0.38	0.00	0.00	1.51	1.51
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	24.44	3.58	1.96	2.61	1.63	0.00	0.00	1.30	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	11.33	2.18	0.44	1.31	1.31	0.00	0.00	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	31.66	4.98	2.26	3.62	1.81	0.00	0.00	1.81	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	16.76	2.65	2.65	3.53	0.00	0.00	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	19.28	2.66	0.00	1.99	1.33	0.00	0.00	0.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	23.31	0.99	2.48	3.47	2.48	0.00	0.00	2.98	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	14.55	4.59	0.77	1.15	0.00	0.00	0.00	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	33.87	6.05	2.42	3.33	1.51	0.00	0.30	0.91	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	28.73	8.40	1.77	4.42	1.33	0.22	0.44	0.66	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	25.07	2.71	1.36	5.42	2.03	0.00	0.00	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	117.52	20.44	0.00	25.55	15.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	18.90	2.44	0.61	2.44	1.22	0.00	0.61	0.61	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	24.86	3.46	0.94	0.63	1.57	0.00	0.63	2.52	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	20.28	3.63	1.51	4.54	1.21	0.00	0.00	0.91	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	28.48	3.96	0.00	5.54	1.58	0.00	0.79	2.37	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	47.61	6.80	3.40	4.53	2.27	0.00	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	136.56	10.12	5.06	5.06	10.12	0.00	0.00	5.06	5.06
Myoblast, donor1	11241-116D8	30.06	7.08	3.73	1.99	1.86	0.37	0.25	0.37	0.50
Myoblast, donor2	11322-117D8	25.51	8.63	2.88	1.53	1.53	0.38	0.19	0.19	0.58
Myoblast, donor3	11398-118D3	34.64	5.89	4.88	3.70	2.52	1.01	0.34	0.34	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	27.00	3.79	1.17	1.31	1.17	0.15	0.00	0.15	0.00
Natural Killer Cells, donor1	11230-116C6	20.91	15.99	1.85	3.08	0.92	0.31	0.31	0.00	0.62
Natural Killer Cells, donor2	11311-117C6	13.87	17.49	0.60	3.32	0.30	0.30	0.30	0.30	0.00
Natural Killer Cells, donor3	11387-118C1	18.41	16.20	0.18	2.76	0.92	0.18	0.18	0.18	0.18
Neural stem cells, donor1	11275-116H6	90.73	26.49	3.99	10.16	6.53	0.00	0.36	0.00	0.73
Neural stem cells, donor2	11352-117H2	51.99	26.96	1.93	11.55	3.85	0.00	0.00	1.93	0.00
Neurons, donor1	11494-119E9	55.76	15.93	1.14	11.38	3.41	0.00	0.00	0.00	0.00
Neurons, donor2	11574-120E8	69.13	12.55	4.62	5.28	7.71	0.22	0.22	0.22	0.22
Neurons, donor3	11655-122E8	38.64	16.44	1.64	9.04	2.47	0.82	0.00	0.82	1.64
Neutrophils, donor1	11233-116C9	14.85	5.57	3.71	0.00	0.93	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	2.90	11.60	0.00	0.00	2.90	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	27.49	9.16	1.22	0.00	0.61	0.61	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	32.53	5.70	5.82	4.99	1.42	0.00	0.36	0.47	1.31
Nucleus Pulposus Cell, donor2	11409-118E5	23.12	2.60	2.28	5.86	0.33	0.33	0.98	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	18.05	6.82	3.21	4.01	0.80	0.00	0.00	0.60	0.40
Olfactory epithelial cells, donor1	11933-125I7	16.38	6.33	3.03	1.10	0.41	0.28	0.14	0.28	0.55
Olfactory epithelial cells, donor2	11934-125I8	32.42	7.38	2.46	1.30	0.87	1.01	0.43	0.29	0.87
Olfactory epithelial cells, donor3	11935-125I9	29.97	7.95	1.70	1.36	1.14	0.68	0.45	0.57	0.57
Olfactory epithelial cells, donor4	11936-126A1	24.15	6.53	1.75	1.46	0.29	0.39	0.10	0.10	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	34.30	4.21	1.81	3.61	3.01	0.00	0.60	0.60	1.81
Osteoblast - differentiated, donor1	11276-116H7	18.93	5.53	1.91	2.34	1.06	0.00	0.43	0.21	0.21
Osteoblast - differentiated, donor2	11353-117H3	10.29	2.29	0.00	1.14	0.00	0.00	0.00	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	26.07	9.31	0.62	1.86	0.62	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	16.61	4.10	0.98	0.98	0.98	0.59	0.39	0.20	0.78
Osteoblast, donor2	11354-117H4	35.12	8.43	5.62	4.92	4.21	2.11	0.00	0.70	0.70
Osteoblast, donor3	11426-118G4	14.57	6.40	1.60	1.07	0.71	0.36	0.00	0.18	0.18
Pancreatic stromal cells, donor1	11249-116E7	45.66	8.84	3.62	3.87	1.52	1.26	0.42	1.18	0.93
Pericytes, donor1	11491-119E6	3.23	1.34	0.56	0.56	0.45	0.00	0.00	0.00	0.11
Pericytes, donor2	11571-120E5	6.34	2.94	0.68	0.68	0.45	0.00	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	14.44	4.88	0.61	0.41	0.20	0.00	0.00	0.00	0.00
Perineurial Cells, donor1	11499-119F5	42.61	6.56	3.05	2.03	1.13	0.45	0.34	0.34	1.13
Perineurial Cells, donor2	11579-120F4	36.80	7.54	4.14	4.69	1.47	0.37	0.09	0.37	1.47
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	23.27	13.71	0.96	2.55	0.64	0.00	0.00	0.00	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	12.00	8.82	1.47	1.47	0.00	0.24	0.24	0.00	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	11.26	11.26	1.29	0.13	0.26	0.13	0.13	0.00	0.26
Placental Epithelial Cells, donor1	11278-116H9	10.04	5.50	0.24	0.72	0.24	0.24	0.00	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	23.29	6.65	3.33	0.00	0.00	0.00	0.00	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	7.07	3.14	0.00	0.59	0.79	0.20	0.00	0.20	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	12.03	4.75	0.95	0.63	0.95	0.32	0.00	0.63	0.63
Preadipocyte - breast, donor1	11467-119B9	24.20	9.57	2.63	2.06	1.69	0.94	0.19	0.00	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	18.53	4.44	1.70	0.65	0.65	0.13	0.00	0.26	0.13
Preadipocyte - breast, donor2	11328-117E5	25.89	5.85	2.70	1.80	1.35	0.68	0.45	0.23	0.45
Preadipocyte - omental, donor1	11468-119C1	33.14	12.15	2.45	2.66	1.92	0.75	0.21	0.43	0.64
Preadipocyte - omental, donor2	11329-117E6	27.50	8.29	4.80	2.18	2.18	0.87	0.87	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	32.52	9.74	2.15	3.29	1.15	1.58	0.14	0.43	0.72
Preadipocyte - perirenal, donor1	11469-119C2	2.95	3.94	0.00	0.98	0.98	0.98	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	13.21	4.61	1.84	1.23	1.54	1.54	0.61	0.31	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	30.28	8.68	3.36	2.83	1.06	0.71	0.00	0.35	1.06
Preadipocyte - subcutaneous, donor3	11428-118G6	25.71	10.56	2.55	2.89	1.02	0.34	0.34	0.17	0.85
Preadipocyte - visceral, donor1	11280-116I2	37.82	11.83	3.91	2.51	1.21	1.12	0.93	0.37	1.02
Preadipocyte - visceral, donor2	11357-117H7	38.19	8.74	4.14	2.30	3.68	0.92	0.00	0.92	1.38
Preadipocyte - visceral, donor3	11429-118G7	19.96	4.91	3.03	1.67	0.84	0.21	0.10	0.21	0.42
Prostate Epithelial Cells (polarized), donor1	11253-116F2	30.47	7.24	1.66	3.62	2.26	0.45	0.15	0.15	0.00
Prostate Epithelial Cells, donor2	11331-117E8	17.20	6.77	2.30	0.68	1.22	1.22	1.62	0.14	0.27
Prostate Epithelial Cells, donor3	11404-118D9	20.64	3.74	1.16	0.37	0.31	0.43	1.04	0.12	0.31
Prostate Stromal Cells, donor1	11254-116F3	30.75	8.66	4.21	2.62	0.80	0.80	0.11	0.80	0.80
Prostate Stromal Cells, donor2	11332-117E9	32.63	10.22	4.66	0.72	0.90	0.72	0.00	0.18	0.72
Prostate Stromal Cells, donor3	11405-118E1	28.05	7.40	3.23	3.55	0.83	0.00	0.21	0.21	0.83
Renal Cortical Epithelial Cells, donor1	11516-119H4	9.49	1.82	1.46	1.09	0.00	0.00	0.00	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	42.21	5.06	2.91	1.46	1.46	0.83	0.07	0.21	0.55
Renal Epithelial Cells, donor1	11517-119H5	3.55	1.52	0.51	1.01	0.00	0.00	0.00	0.00	0.51
Renal Epithelial Cells, donor2	11597-120H4	7.82	0.71	0.00	0.71	0.71	0.00	0.00	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	51.56	7.09	2.65	1.80	1.48	0.42	0.11	0.32	1.38
Renal Glomerular Endothelial Cells, donor1	11514-119H2	4.09	1.36	0.68	0.00	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	12.80	2.70	1.08	2.02	0.67	0.13	0.13	0.00	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	28.42	5.11	1.78	2.44	1.33	0.22	0.00	0.67	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.32	1.33	0.00	1.33	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	9.46	1.54	0.66	0.44	1.32	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	12.54	5.02	0.63	0.00	0.63	0.00	0.00	1.25	0.00
Renal Mesangial Cells, donor3	11679-122H5	3.88	0.83	0.83	0.28	0.00	0.00	0.00	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	16.64	3.76	1.34	1.07	0.54	0.00	0.27	0.54	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	9.70	1.27	0.42	0.00	0.00	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	12.15	2.12	0.39	0.96	0.39	0.19	0.00	0.00	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	35.00	8.30	3.37	1.04	1.30	0.52	0.00	0.52	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	15.92	3.13	1.14	1.14	0.28	0.28	0.00	0.00	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	6.17	2.06	0.00	0.00	1.03	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	38.39	12.04	2.01	4.01	2.01	0.00	0.00	0.50	1.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	41.03	12.56	2.27	2.94	1.47	0.40	0.27	1.07	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	21.44	8.04	3.57	1.79	2.68	0.00	0.00	0.00	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	44.58	7.71	2.75	4.40	3.30	0.55	1.65	0.00	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	31.90	13.34	1.16	6.38	2.32	0.58	0.00	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	15.73	12.74	2.21	2.47	1.43	0.00	0.13	0.26	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	14.70	10.33	1.09	1.79	0.60	0.20	0.10	0.10	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	21.42	10.04	1.67	2.12	1.34	0.67	0.11	0.33	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	21.09	9.92	2.23	2.60	1.36	0.37	0.00	0.00	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	12.12	8.27	2.45	1.52	0.93	0.12	0.00	0.12	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	20.57	10.63	1.85	1.62	1.39	0.69	0.00	0.23	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	7.94	8.08	1.78	1.51	1.10	0.41	0.00	0.14	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	13.92	8.93	1.82	1.82	0.76	0.15	0.00	0.15	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	18.28	10.21	1.79	2.51	1.25	1.08	0.18	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	8.61	9.90	2.15	2.15	0.72	0.00	0.14	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	14.27	9.34	1.61	1.72	0.75	0.11	0.00	0.11	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	15.27	12.17	1.77	2.43	0.44	0.66	0.00	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	5.16	8.03	0.96	1.91	0.96	0.00	0.00	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	13.69	8.01	1.49	1.86	0.65	0.09	0.19	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	23.86	17.29	2.63	3.19	2.25	0.38	0.19	0.38	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	11.28	9.69	1.33	2.12	1.06	0.13	0.00	0.13	0.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	16.94	9.64	2.24	1.56	0.97	0.49	0.00	0.10	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	21.01	11.08	2.29	3.06	1.34	1.34	0.00	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	10.25	9.40	1.60	2.56	0.75	0.21	0.11	0.11	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	10.65	9.25	2.52	1.68	1.68	0.00	0.00	0.28	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	16.92	10.60	1.88	2.22	1.03	0.17	0.00	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	7.29	7.84	1.09	2.01	0.91	0.00	0.00	0.00	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	13.61	9.93	1.10	2.58	0.98	0.25	0.00	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	13.70	13.97	1.48	2.42	1.61	0.13	0.00	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	9.20	13.92	2.12	3.54	0.24	0.24	0.00	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	14.68	12.30	1.98	3.17	0.40	0.40	0.00	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	14.03	13.10	1.87	2.81	1.64	0.00	0.23	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	8.50	11.61	1.04	1.66	1.04	0.62	0.00	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	17.03	8.63	1.11	4.65	0.66	0.22	0.00	0.22	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	15.04	9.82	0.84	2.30	1.04	0.21	0.00	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	11.44	9.42	2.56	1.88	1.08	0.00	0.00	0.27	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	11.92	10.90	0.85	3.41	0.68	0.17	0.17	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	15.81	11.37	1.54	2.31	0.96	0.58	0.00	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	9.11	9.46	2.24	3.27	1.38	0.34	0.17	0.17	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	14.27	10.01	1.51	2.19	0.69	0.27	0.14	0.27	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	16.75	9.19	1.81	2.96	1.64	0.16	0.00	0.49	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	6.82	6.65	1.02	2.39	1.53	0.00	0.17	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	20.86	11.54	2.81	1.78	0.59	0.00	0.15	0.30	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	21.32	8.26	1.33	2.13	1.33	0.00	0.00	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	11.20	8.57	1.80	4.15	1.11	0.55	0.00	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	14.52	9.05	0.95	2.14	0.71	0.48	0.00	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	23.98	10.28	1.01	1.81	1.81	0.00	0.20	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	13.47	8.66	2.17	3.58	0.94	0.00	0.09	0.09	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	25.50	9.08	3.49	6.64	2.45	0.35	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	22.67	9.67	2.12	2.72	1.81	0.30	0.00	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	12.73	9.06	0.98	2.33	0.49	0.00	0.12	0.00	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	40.75	17.76	3.93	7.86	3.93	0.87	0.00	0.15	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	31.03	6.08	1.22	2.43	1.83	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	8.44	7.84	1.81	1.51	0.90	0.60	0.00	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	21.49	8.14	1.36	3.85	1.58	0.00	0.23	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	24.26	5.39	1.20	6.29	2.40	0.30	1.50	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	14.76	9.68	1.53	4.60	1.77	0.47	0.24	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	13.66	8.11	1.71	3.42	0.00	0.00	0.21	0.43	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	21.03	6.61	0.60	5.41	1.80	1.20	0.00	0.00	0.60
Schwann Cells, donor1	11498-119F4	5.27	3.20	0.19	0.19	0.19	0.00	0.00	0.00	0.00
Schwann Cells, donor2	11578-120F3	13.61	3.40	0.00	3.40	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	24.98	6.35	1.31	1.97	1.10	0.00	0.22	0.00	0.00
Sebocyte, donor1	11220-116B5	26.29	6.03	4.93	0.00	1.64	0.55	1.64	0.00	1.10
Sebocyte, donor2	11301-117B5	27.11	5.51	2.30	2.30	0.92	0.46	1.84	0.46	1.84
Sebocyte, donor3	11378-118B1	14.84	3.92	1.44	2.47	1.03	0.41	0.21	0.00	0.82
Sertoli Cells, donor1	11255-116F4	46.38	14.91	3.31	1.66	1.66	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	31.07	11.30	0.00	0.00	0.00	2.82	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	30.88	7.13	1.85	2.20	2.02	0.26	0.09	0.79	0.53
Skeletal Muscle Cells, donor2	11358-117H8	10.12	5.06	0.00	0.72	0.72	0.00	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	10.03	7.52	0.00	0.00	0.00	0.00	0.00	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	20.27	5.34	1.41	0.79	0.63	0.31	0.00	0.16	0.47
Skeletal Muscle Cells, donor5	11455-119A6	19.32	6.99	2.08	1.04	0.89	0.30	0.30	0.59	0.59
Skeletal Muscle Cells, donor6	11459-119B1	25.39	7.23	2.46	1.54	0.92	0.31	0.15	0.46	1.23
Skeletal Muscle Satellite Cells, donor1	11240-116D7	50.91	7.94	3.65	3.53	2.02	0.38	0.25	0.50	1.89
Skeletal Muscle Satellite Cells, donor2	11321-117D7	33.25	7.99	1.85	3.71	1.14	0.57	0.14	1.14	1.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	33.43	7.84	2.88	1.88	1.29	0.79	0.00	0.30	0.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	41.96	9.10	2.27	4.21	3.29	0.59	0.00	1.35	0.51
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	13.75	4.34	1.45	2.90	2.17	0.00	0.00	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	9.22	2.75	0.69	0.69	0.28	0.28	0.00	0.28	0.14
Skin - palm, donor1	10286-104F7	16.12	2.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	11.39	4.47	2.16	0.58	0.86	0.43	1.01	0.14	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	31.08	13.90	4.91	0.00	2.45	4.09	0.82	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	12.59	2.86	1.30	1.04	0.52	0.26	0.39	0.00	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	38.51	8.76	3.89	1.53	1.53	0.97	4.45	0.00	0.70
Small Airway Epithelial Cells, donor2	11334-117F2	25.18	7.17	2.11	0.84	0.28	0.42	1.55	0.14	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	45.25	11.21	5.07	5.07	1.48	1.06	2.54	0.00	1.06
Small Airway Epithelial Cells, donor3	11406-118E2	20.09	6.30	2.32	0.97	0.37	0.37	1.95	0.07	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	16.05	9.26	4.01	3.39	1.54	0.93	0.62	0.31	1.23
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	9.34	4.89	0.89	1.11	0.22	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	25.86	5.88	0.59	0.00	1.18	0.59	0.00	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	12.60	4.42	0.66	0.88	0.22	0.44	0.22	0.22	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	12.21	4.73	1.58	0.39	2.36	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	17.77	6.95	0.77	0.77	0.77	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	12.01	14.01	3.00	1.00	2.00	0.00	1.00	1.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	15.17	3.19	1.46	1.86	0.53	0.27	0.00	0.53	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	26.82	9.09	1.99	0.66	1.33	0.44	0.22	0.00	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	24.07	6.53	2.05	2.30	0.38	0.26	0.00	0.13	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	30.93	9.77	4.23	2.28	0.98	0.65	0.33	0.00	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	38.98	8.56	4.43	4.13	0.89	0.00	0.30	0.59	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	23.63	7.55	1.57	1.28	0.85	0.85	0.14	0.14	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	6.67	1.79	0.81	0.65	0.16	0.16	0.00	0.16	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	18.57	1.83	0.61	1.83	0.30	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	11.37	7.07	2.53	2.78	0.76	0.76	0.00	0.51	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	5.72	1.91	0.95	0.00	0.48	0.00	0.00	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	22.12	5.16	2.80	1.92	0.88	0.44	0.15	0.74	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	26.26	6.03	1.72	0.86	0.43	0.00	0.22	0.00	1.29
Smooth Muscle Cells - Colonic, donor3	11396-118D1	24.35	6.72	1.26	1.68	0.42	0.63	0.31	0.31	0.94
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	12.06	3.09	1.08	0.93	0.00	0.31	0.00	0.31	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	9.70	1.08	3.23	2.16	1.08	0.00	0.00	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	8.97	3.59	1.49	1.79	0.30	0.00	0.00	0.60	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	5.80	2.05	0.00	0.34	0.68	0.34	0.00	0.00	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	38.01	4.63	2.91	1.49	0.71	0.08	0.16	0.39	0.94
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	36.03	10.37	3.62	5.33	1.31	0.70	0.10	1.01	0.50
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	28.90	6.60	2.28	1.37	1.14	0.46	0.00	0.00	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	9.06	2.42	0.60	0.00	1.21	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	34.44	8.48	3.97	4.77	1.06	1.06	0.00	0.79	1.59
Smooth Muscle Cells - Prostate, donor1	11257-116F6	22.64	9.85	3.46	2.00	0.93	0.40	0.13	0.27	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	28.55	6.26	2.50	1.88	1.25	0.88	0.00	0.38	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	25.37	5.83	1.01	2.54	0.76	0.00	0.76	0.25	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	31.96	6.94	3.02	2.26	2.56	0.15	0.30	0.75	1.21
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	8.25	0.00	1.50	0.75	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	2.58	1.29	0.00	1.29	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	18.60	6.51	0.47	1.86	0.93	0.00	0.00	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	16.66	6.56	1.01	2.02	0.00	0.50	0.00	0.00	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	11.60	7.83	2.82	1.88	0.31	0.31	0.00	0.63	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	11.50	1.47	0.59	0.00	0.88	0.00	0.00	0.00	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	43.90	8.33	3.67	1.67	1.25	0.83	0.00	0.42	0.92
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	25.69	4.20	2.80	1.87	0.47	0.00	0.47	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	19.14	6.33	3.60	1.01	1.58	0.29	0.00	0.29	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	15.30	4.08	0.76	1.78	0.51	0.25	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	8.65	3.20	1.32	1.13	0.56	0.19	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	51.43	7.13	5.59	4.47	2.10	0.98	0.00	0.42	1.12
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	38.21	8.04	4.52	5.11	1.51	0.34	0.00	0.25	0.75
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	2.86	1.43	0.48	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	18.59	5.87	1.71	0.49	0.24	0.73	0.00	0.00	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	19.44	7.07	3.31	2.65	1.33	0.66	0.00	0.00	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	23.99	4.97	4.10	1.17	0.59	0.29	0.29	0.29	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	22.74	4.86	0.97	2.92	1.94	0.00	0.19	0.58	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	25.92	3.97	1.59	1.85	1.32	0.26	0.26	0.53	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	36.82	4.84	5.95	3.72	1.12	0.74	0.00	1.86	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	31.26	6.83	3.23	1.80	2.52	1.08	0.00	1.80	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	24.13	5.11	2.56	2.56	1.14	0.00	0.85	0.28	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	21.66	5.91	1.58	1.18	0.79	0.79	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	30.47	5.84	3.05	5.84	0.76	0.51	0.25	0.25	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	30.35	4.39	0.80	2.00	1.60	0.40	0.00	0.40	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	21.74	5.02	0.84	5.85	0.42	0.42	1.25	1.25	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	18.79	4.58	2.29	3.67	1.83	0.00	0.92	0.00	0.00
Synoviocyte, donor1	11291-117A4	29.96	10.27	2.69	2.19	0.67	0.34	0.17	0.00	0.50
Synoviocyte, donor2	11368-117I9	25.48	8.88	1.68	1.84	1.17	0.84	0.50	0.17	0.17
Synoviocyte, donor3	11440-118H9	24.35	6.48	1.56	1.79	0.45	0.22	0.67	0.67	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	8.22	1.43	0.71	0.00	0.71	0.71	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	5.95	3.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	10.88	2.08	1.62	0.93	0.00	0.23	0.00	0.23	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	25.45	4.52	1.51	0.93	0.43	0.36	4.80	0.00	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	6.19	3.87	1.16	0.00	0.00	0.77	0.00	0.00	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	3.44	4.01	0.57	0.00	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	43.43	11.20	2.21	3.08	1.60	0.12	0.37	0.49	0.25
Urethra, donor2	10319-105A4	19.78	14.39	1.80	0.00	1.80	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	9.56	2.13	1.33	0.27	0.80	0.00	0.80	0.00	0.80
Urothelial Cells, donor2	11600-120H7	4.81	2.80	0.80	0.40	0.00	0.00	0.40	0.00	0.00
Urothelial Cells, donor3	11681-122H7	4.13	2.06	0.23	0.23	0.23	0.00	0.23	0.00	0.00
Urothelial cells, donor0	11216-116B1	39.90	4.24	2.67	1.11	0.45	0.00	2.67	0.45	1.11
Whole blood (ribopure), donor090309, donation1	12179-129A1	21.35	13.35	2.67	1.78	0.89	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	37.17	5.72	1.43	0.00	2.86	0.00	0.00	0.00	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	26.70	7.53	1.37	0.68	0.68	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	34.43	9.99	0.69	0.69	0.69	0.69	0.00	0.00	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	36.60	12.20	1.16	0.58	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	18.74	8.33	0.00	1.04	1.04	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	33.96	10.10	0.92	0.00	1.84	0.92	0.00	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	27.39	7.30	0.91	0.00	0.91	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	50.08	13.94	3.33	2.96	2.22	0.12	0.62	0.25	1.48
Wilms' tumor cell line:HFWT	10597-108E3	17.60	7.04	3.52	6.16	0.00	0.00	0.00	2.64	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	36.59	9.78	6.98	1.12	0.28	1.40	2.79	0.00	1.12
achilles tendon, donor2	10292-104G4	12.40	4.13	4.13	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	47.93	23.71	5.61	6.37	5.35	1.27	0.51	0.51	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	38.08	34.36	3.25	5.80	1.39	0.70	1.39	0.93	1.16
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	38.11	18.99	3.21	2.37	1.54	1.78	0.00	0.12	0.83
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	57.14	19.05	6.80	4.35	1.90	0.54	0.00	3.27	1.09
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	21.92	6.75	1.12	0.56	1.41	0.28	0.28	0.56	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	33.84	9.73	3.38	1.69	2.33	0.21	0.21	0.85	0.85
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	16.33	5.99	2.18	3.27	1.09	0.00	1.09	0.27	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	25.12	7.05	3.53	6.17	1.76	0.00	0.00	3.08	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	28.59	6.94	1.23	1.63	0.82	0.00	0.41	1.23	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	25.24	5.82	3.49	6.21	0.78	0.78	2.33	0.39	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	13.80	12.51	2.21	0.37	0.37	0.00	0.18	0.55	0.74
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	15.60	7.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	34.62	8.83	6.27	5.58	1.63	0.23	0.70	0.70	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	25.37	16.05	3.88	1.81	1.04	1.81	0.00	0.00	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	19.58	11.40	1.46	2.92	0.88	1.46	0.00	0.29	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	27.89	8.83	1.86	1.39	0.46	0.00	0.93	0.00	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	21.80	11.10	0.82	1.23	0.41	0.41	0.00	0.82	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	4.30	6.75	1.23	0.00	0.00	0.31	0.00	0.92	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	27.31	15.36	4.27	1.71	0.85	0.43	0.43	0.85	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	22.14	13.04	6.07	2.73	0.61	0.61	0.91	0.30	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	28.40	15.41	5.54	1.93	0.48	0.72	0.00	0.72	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	17.37	7.13	1.11	0.89	2.23	0.89	0.00	0.45	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	20.01	17.34	2.00	2.00	0.67	1.00	0.00	0.00	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	11.15	14.87	1.86	3.72	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	22.98	15.82	3.39	1.13	0.38	2.26	0.00	0.38	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	24.42	4.80	1.31	3.05	0.87	0.00	0.87	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	39.36	5.62	0.00	11.25	1.87	0.00	3.75	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	36.27	9.89	1.88	3.30	0.47	0.00	0.71	0.47	0.47
adipose tissue, adult, pool1	10010-101C1	27.77	7.45	0.78	2.17	1.55	0.47	0.00	0.47	0.16
adipose, donor1	10184-103D4	141.91	16.42	6.45	8.21	5.28	0.00	0.00	0.59	2.93
adipose, donor2	10185-103D5	41.77	5.27	1.22	1.62	2.03	0.00	0.41	1.22	0.00
adipose, donor3	10186-103D6	46.83	9.53	2.72	3.00	2.45	0.27	0.82	1.36	0.54
adipose, donor4	10187-103D7	53.74	13.00	0.87	6.93	0.87	0.00	0.00	0.87	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	44.35	6.15	3.16	4.10	0.95	0.00	0.16	0.32	2.05
adrenal gland, adult, pool1	10081-102A9	25.46	14.55	0.00	0.00	3.64	0.00	0.00	0.00	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	24.01	4.40	2.53	1.87	1.60	0.67	0.40	0.13	0.67
alveolar cell carcinoma cell line:SW 1573	10708-109H6	29.30	9.65	3.22	1.79	0.36	0.71	0.00	1.07	0.71
amniotic membrane cells, donor1	12235-129G3	24.81	5.56	1.85	1.16	0.00	0.00	0.00	0.23	0.23
amniotic membrane cells, donor2	12236-129G4	35.84	7.10	2.03	1.69	1.69	0.34	0.00	0.34	0.68
amniotic membrane cells, donor3	12237-129G5	38.89	4.42	0.88	0.88	1.18	0.00	0.29	0.59	0.29
amygdala - adult, donor10196	10167-103B5	47.43	9.49	3.56	3.56	2.37	0.00	0.00	0.00	1.19
amygdala, adult, donor10252	10151-102I7	60.63	10.95	2.64	2.84	3.65	0.41	0.00	0.41	1.01
amygdala, newborn, donor10223	10360-105E9	26.79	5.81	1.94	3.23	2.26	0.32	0.00	0.00	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	22.28	3.57	2.67	1.53	0.64	0.00	0.00	0.00	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	12.13	11.25	2.21	0.44	0.44	1.10	0.22	0.44	1.10
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	26.72	6.01	1.00	2.67	1.00	0.00	0.00	0.33	1.00
aorta, adult, pool1	10052-101G7	21.77	3.53	1.57	1.57	0.39	0.20	0.00	0.00	0.39
appendix, adult	10189-103D9	24.06	10.09	1.55	3.10	1.16	0.39	0.00	0.00	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	44.37	16.85	3.78	0.69	1.72	0.00	0.34	0.34	1.03
artery, adult	10190-103E1	10.87	19.02	0.00	4.08	0.00	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	63.02	26.22	3.04	3.04	2.17	0.87	0.29	0.14	0.29
b cell line:RPMI1788	10427-106D4	23.94	8.48	3.27	3.27	0.74	0.59	0.89	0.59	1.34
basal cell carcinoma cell line:TE 354.T	10702-109G9	31.07	6.66	3.33	1.39	2.50	0.83	0.28	1.11	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	42.37	12.40	6.55	3.08	0.99	0.30	0.10	0.79	1.29
bile duct carcinoma cell line:TFK-1	10496-107C1	16.57	17.57	2.34	2.18	1.00	1.17	0.00	0.17	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	21.81	7.83	9.51	1.68	0.00	0.00	1.12	1.12	0.56
bladder, adult, pool1	10011-101C2	24.99	5.32	1.96	2.50	0.65	0.11	0.22	0.11	0.33
blood, adult, pool1	10053-101G8	19.93	2.21	2.21	0.00	0.00	0.00	0.00	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	19.70	6.85	1.71	1.71	0.00	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	33.74	11.47	3.37	0.67	0.00	0.67	0.00	0.67	0.00
brain, adult, donor1	10084-102B3	9.23	3.08	0.00	1.03	2.05	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	23.61	7.24	2.56	3.56	2.00	0.45	0.00	0.00	0.45
brain, fetal, pool1	10085-102B4	45.41	10.69	0.00	10.69	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	44.93	5.29	4.29	1.65	0.66	0.66	0.66	0.66	1.65
breast carcinoma cell line:MDA-MB-453	10419-106C5	36.07	4.37	2.12	2.12	2.12	0.50	0.37	0.37	0.50
breast, adult, donor1	10080-102A8	23.36	5.05	0.63	0.00	0.63	0.00	0.00	0.00	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	37.73	7.75	2.41	0.64	0.13	0.13	1.14	0.13	1.14
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	28.76	5.26	1.86	0.93	0.00	0.31	1.24	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	145.27	11.74	16.35	11.74	4.37	1.61	2.53	1.15	5.76
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	33.65	10.17	1.21	3.15	0.97	0.24	0.97	0.97	0.00
carcinoid cell line:NCI-H1770	10703-109H1	39.49	10.81	1.41	1.88	2.35	0.00	0.00	0.00	1.41
carcinoid cell line:NCI-H727	10735-110B6	31.50	11.05	1.75	2.84	1.31	0.44	0.11	0.00	0.55
carcinoid cell line:SK-PN-DW	10719-109I8	11.41	7.92	0.63	1.58	0.63	0.00	0.00	0.00	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	31.68	14.37	2.93	1.06	1.06	0.53	1.06	0.00	0.27
caudate nucleus - adult, donor10196	10177-103C6	57.57	11.51	0.00	0.00	1.15	0.00	0.00	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	48.86	12.72	1.34	3.85	1.67	0.33	0.00	0.17	0.33
caudate nucleus, adult, donor10258	10379-105H1	19.10	9.93	0.76	2.29	1.53	0.76	0.00	0.76	1.53
caudate nucleus, newborn, donor10223	10354-105E3	41.38	11.72	3.30	4.03	3.66	0.73	0.00	1.83	1.10
cerebellum - adult, donor10196	10173-103C2	34.96	2.91	5.83	2.91	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	51.03	11.74	1.07	3.84	2.99	0.64	0.00	0.21	0.21
cerebellum, adult, pool1	10083-102B2	13.45	6.90	1.03	0.69	0.34	0.69	0.00	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	48.99	9.13	1.66	12.45	2.49	0.00	0.83	0.00	0.00
cerebral meninges, adult	10188-103D8	20.93	10.09	1.51	1.76	1.26	0.25	0.00	0.50	0.76
cerebrospinal fluid, donor2	10294-104G6	10.23	3.65	0.73	0.00	0.73	0.00	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	49.60	13.08	7.76	2.73	2.01	0.86	2.59	0.29	0.58
cervical cancer cell line:ME-180	10553-107I4	19.89	16.24	2.32	1.16	1.49	0.99	2.32	0.00	0.66
cervix, adult, pool1	10013-101C4	35.17	8.61	2.31	1.47	0.94	0.10	0.31	0.10	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	22.15	11.01	0.84	0.70	1.25	0.00	0.00	0.28	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	13.06	2.61	1.31	0.00	0.00	0.00	2.61	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	20.26	5.72	1.74	1.24	2.11	0.75	0.00	0.25	0.12
choriocarcinoma cell line:SCH	10785-110H2	33.39	13.43	3.82	2.09	0.62	0.49	0.00	0.12	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	15.18	11.15	2.37	0.71	0.24	0.24	0.24	0.00	0.47
chorionic membrane cells, donor1	12238-129G6	24.50	3.99	0.85	0.28	0.28	0.00	0.00	0.00	0.28
chorionic membrane cells, donor2	12239-129G7	30.72	5.37	2.09	0.70	1.19	0.70	0.10	0.20	0.70
chorionic membrane cells, donor3	12240-129G8	31.32	4.40	0.55	1.10	1.10	0.00	0.00	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	17.17	14.14	1.01	2.02	0.00	1.01	0.00	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	25.93	8.64	2.31	2.88	1.15	0.00	0.19	0.19	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	35.27	6.76	4.22	2.96	0.84	0.21	0.21	0.63	1.27
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	23.11	10.79	2.57	1.80	0.00	1.03	0.00	0.26	1.03
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	28.06	15.24	2.90	0.73	0.97	0.73	0.00	0.48	0.97
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	24.84	11.61	1.63	1.63	0.41	1.63	0.00	0.00	1.43
chronic myelogenous leukemia cell line:K562	10454-106G4	26.80	23.26	4.12	2.36	0.88	2.65	0.00	0.00	1.18
chronic myelogenous leukemia cell line:KU812	10409-106B4	72.71	18.24	6.78	3.65	2.61	0.78	0.00	0.00	2.61
clear cell carcinoma cell line:JHOC-5	10638-108I8	49.60	3.66	5.49	2.51	1.14	0.00	0.00	0.46	0.46
clear cell carcinoma cell line:TEN	10636-108I6	24.81	6.25	2.08	2.08	1.04	0.69	0.17	0.00	0.17
colon carcinoma cell line:CACO-2	10513-107D9	49.06	17.76	2.20	3.84	4.03	0.92	0.37	0.55	0.92
colon carcinoma cell line:COLO-320	10420-106C6	42.57	22.04	3.80	2.28	0.76	0.38	0.38	0.00	1.14
colon, adult, donor1	10082-102B1	15.47	3.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	31.37	9.40	1.65	1.41	1.18	0.24	0.12	0.12	0.35
colon, fetal, donor1	10070-101I7	28.43	6.18	3.71	2.47	0.62	0.00	0.62	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	18.33	18.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	125.18	0.00	25.04	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	70.54	29.75	8.50	6.37	5.95	0.85	2.12	2.55	1.27
cord blood derived cell line:COBL-a 24h infection	10453-106G3	40.90	14.34	4.83	3.62	1.81	0.45	2.41	1.81	0.45
cord blood derived cell line:COBL-a untreated	10449-106F8	41.74	10.86	6.35	2.54	1.41	0.85	3.81	0.99	0.56
corpus callosum, adult, pool1	10042-101F6	35.93	11.28	1.99	3.98	3.32	0.55	0.00	0.00	0.55
cruciate ligament, donor2	10295-104G7	17.83	7.29	0.00	0.81	1.62	0.81	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	23.27	5.62	2.41	1.61	1.61	0.00	0.00	0.00	0.00
diencephalon, adult	10193-103E4	29.76	11.52	0.00	2.64	2.40	0.00	0.00	0.24	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	25.03	10.56	2.53	2.98	0.69	0.46	0.69	0.00	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	52.31	7.69	4.36	4.10	2.82	0.26	2.31	0.26	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	45.26	8.43	2.17	6.26	3.37	0.96	1.20	1.20	0.48
ductus deferens, adult	10196-103E7	30.40	14.95	1.50	2.49	1.50	0.50	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	37.45	2.88	2.88	1.44	2.88	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	32.37	8.09	1.47	0.00	0.74	0.00	0.00	0.00	1.47
dura mater, adult, donor1	10041-101F5	16.02	6.52	2.48	1.57	0.99	0.25	0.17	0.00	0.58
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	18.43	57.07	1.33	1.11	1.55	2.44	0.22	0.00	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	20.35	20.35	2.29	1.58	0.72	1.29	0.14	0.00	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	18.50	2.47	1.23	0.62	1.23	0.00	0.00	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	25.43	3.63	0.91	0.00	0.61	0.30	0.30	0.30	1.21
embryonic pancreas cell line:1C3IKEI	10606-108F3	20.38	6.17	0.93	0.62	0.31	0.00	0.00	0.93	0.00
embryonic pancreas cell line:2C6	10603-108E9	23.64	1.31	1.31	1.31	1.31	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	26.48	7.04	2.35	3.69	1.68	0.00	0.00	0.67	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	39.51	11.60	4.89	4.35	2.17	0.72	0.54	0.18	1.27
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	32.65	6.43	1.13	2.09	0.96	0.64	0.00	0.64	0.48
epidermoid carcinoma cell line:A431	10426-106D3	15.67	2.89	0.67	0.33	0.22	0.11	2.00	0.11	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	36.41	12.76	2.53	1.87	1.43	1.10	1.54	0.44	0.77
epididymis, adult	10197-103E8	21.77	10.47	2.30	2.30	1.05	0.00	0.21	0.00	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	37.08	6.39	2.66	1.06	2.13	0.89	0.18	0.35	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	16.12	5.51	0.39	0.39	0.00	0.00	0.00	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	24.90	26.21	1.57	1.31	0.66	2.62	0.00	0.26	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	28.84	35.23	2.26	1.08	1.08	3.25	0.00	0.30	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	26.66	27.56	1.90	0.78	1.01	0.78	0.22	0.34	0.90
esophagus, adult, pool1	10015-101C6	24.74	6.69	2.02	1.06	0.64	0.00	0.42	0.21	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	51.60	11.15	5.51	1.50	1.13	0.25	0.13	0.00	1.88
eye - muscle inferior rectus, donor1	10272-104E2	19.32	2.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	16.83	2.10	2.10	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	5.95	4.46	0.00	0.00	4.46	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	24.08	4.59	1.15	1.15	0.00	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	13.12	0.00	0.00	1.46	0.00	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	35.59	8.14	2.03	4.07	2.03	0.51	0.00	0.00	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	42.31	7.95	5.64	3.97	1.03	0.77	0.51	0.38	1.15
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	54.37	9.26	5.94	3.80	0.24	1.42	0.24	1.19	0.95
frontal lobe, adult, pool1	10040-101F4	36.69	11.73	3.38	2.81	2.53	0.47	0.00	0.28	0.84
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	38.13	9.91	2.40	2.40	1.50	0.00	0.60	0.30	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	80.01	8.32	4.75	4.57	1.65	0.37	0.09	0.09	1.28
gall bladder, adult	10198-103E9	20.28	5.79	1.69	1.93	1.21	0.24	0.48	0.24	0.24
gamma delta positive T cells, donor1	11937-126A2	45.63	12.88	0.00	0.00	1.07	0.54	0.00	0.00	1.07
gamma delta positive T cells, donor2	11938-126A3	32.12	20.54	2.24	1.12	1.12	0.00	0.37	0.00	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	51.96	8.66	5.07	2.32	1.90	0.00	0.42	0.42	0.84
gastric adenocarcinoma cell line:MKN45	10612-108F9	39.46	7.93	3.09	3.09	1.55	0.19	0.39	0.97	0.77
gastric cancer cell line:AZ521	10549-107H9	53.45	28.53	5.41	3.93	2.46	0.66	0.33	0.16	1.48
gastric cancer cell line:GSS	10560-108A2	31.12	10.07	1.83	2.75	0.00	2.75	0.00	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	18.05	8.91	1.14	4.57	3.20	0.23	0.69	0.00	0.46
giant cell carcinoma cell line:LU65	10487-107B1	16.06	5.16	1.15	0.11	0.46	0.23	0.00	0.00	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	24.91	5.74	6.72	1.54	0.70	0.28	0.14	0.70	2.38
glassy cell carcinoma cell line:HOKUG	10688-109F4	51.38	7.23	2.99	2.49	2.99	0.25	2.49	0.50	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	33.57	12.88	2.96	1.37	1.69	1.48	0.11	0.11	0.95
glioblastoma cell line:A172, tech_rep2	10444-106F3	31.04	10.53	3.09	1.83	2.53	0.56	0.14	0.70	0.28
glioblastoma cell line:T98G	10485-107A8	31.46	8.83	3.09	0.99	1.66	0.11	0.33	0.33	0.22
glioma cell line:GI-1	10413-106B8	40.42	4.98	5.27	5.86	2.34	0.00	0.00	0.00	0.59
globus pallidus - adult, donor10196	10175-103C4	45.19	9.48	2.92	3.64	2.19	0.00	0.00	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	72.98	17.82	1.71	7.81	2.93	0.24	0.49	0.24	0.73
globus pallidus, adult, donor10258	10367-105F7	39.71	19.17	2.74	6.85	2.74	1.37	0.00	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	25.05	8.53	2.13	2.66	0.53	0.53	0.00	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	31.81	0.00	0.00	2.45	4.89	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	0.00	21.86	0.00	0.00	0.00	0.00	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	5.23	5.23	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	24.32	4.80	1.28	0.32	0.64	0.00	0.00	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	28.01	8.26	2.30	7.35	1.84	0.00	0.00	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	22.86	8.23	2.29	3.66	0.46	0.00	0.46	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	21.90	5.15	3.22	5.80	3.22	0.00	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	15.81	4.31	0.00	2.87	1.44	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	20.58	6.86	2.74	2.06	0.69	0.00	1.37	0.00	0.00
hIPS, biol_rep3	14382-156B8	30.90	5.52	2.21	3.31	2.21	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	18.68	10.63	2.59	2.30	0.86	0.86	4.88	0.00	0.86
heart - mitral valve, adult	10205-103F7	21.23	7.18	0.30	3.59	0.30	0.60	0.60	1.49	0.00
heart - pulmonic valve, adult	10206-103F8	26.41	7.32	1.05	1.57	2.09	0.00	0.00	0.26	0.00
heart - tricuspid valve, adult	10207-103F9	12.49	9.16	2.50	0.00	0.00	0.00	0.00	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	20.61	4.90	0.41	0.61	0.61	0.00	0.00	0.41	0.82
heart, adult, diseased, donor1	10051-101G6	16.18	2.55	0.00	0.85	0.43	0.00	0.00	0.43	0.00
heart, adult, pool1	10016-101C7	15.18	5.52	0.46	0.00	0.69	0.00	0.00	0.00	0.00
heart, fetal, pool1	10046-101G1	37.68	10.17	1.85	1.85	0.92	0.00	0.00	0.00	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	27.77	6.79	0.93	1.23	0.00	0.31	0.00	0.62	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	15.46	5.95	1.19	1.19	1.19	0.00	0.00	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	31.93	12.60	0.99	1.44	1.88	0.33	0.33	0.00	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	28.64	14.20	0.73	1.58	1.58	0.36	0.00	0.24	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	33.55	15.16	1.72	1.11	1.01	0.81	0.51	0.20	0.30
hepatoma cell line:Li-7	10484-107A7	16.13	8.01	2.00	1.00	0.78	0.22	0.22	0.00	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	29.65	8.64	3.92	2.31	0.40	0.20	0.00	0.10	1.41
hippocampus - adult, donor10196	10169-103B7	52.99	5.68	0.95	3.79	0.95	0.00	0.00	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	49.19	13.27	1.43	1.63	1.22	0.20	0.00	0.61	0.20
hippocampus, adult, donor10258	10374-105G5	31.87	6.47	1.49	0.50	0.50	0.00	0.00	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	20.44	7.05	0.70	2.11	1.76	1.06	0.00	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	83.62	22.58	2.44	13.43	3.05	0.61	1.83	1.22	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	40.65	11.78	2.36	7.66	4.52	0.39	0.79	0.39	0.79
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	49.51	16.50	1.52	4.06	2.79	0.25	0.76	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	45.67	8.46	0.56	2.26	3.95	0.00	0.00	0.00	1.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	56.55	6.20	2.84	2.32	0.77	0.52	0.00	0.00	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	47.07	11.77	2.28	2.66	1.90	0.00	0.00	0.00	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	55.18	16.35	3.50	10.51	4.09	0.00	0.29	0.29	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	54.93	12.71	1.94	5.60	2.37	0.22	0.43	0.22	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	47.13	12.93	1.67	4.17	4.59	0.00	0.83	1.25	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	52.33	19.42	3.32	6.39	4.50	0.24	0.00	1.42	1.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	46.29	16.07	2.89	4.66	3.38	0.48	0.48	0.48	0.32
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	45.11	18.18	5.39	6.06	5.39	0.00	1.35	0.67	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	45.54	10.33	2.35	4.23	4.69	0.16	0.47	0.31	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	41.27	8.84	0.49	5.90	2.95	0.00	0.98	0.49	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	82.04	17.46	5.24	6.98	4.36	0.00	3.49	1.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	62.05	9.55	2.10	2.29	1.15	0.19	0.00	0.00	0.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	52.76	6.98	1.74	1.31	3.05	0.44	0.00	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	79.46	14.99	3.00	5.00	2.50	0.00	0.00	0.00	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	51.43	5.27	2.45	2.26	3.20	0.00	0.19	0.38	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	60.93	4.55	2.27	5.00	1.36	0.00	0.45	0.91	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	57.01	4.07	3.76	3.76	2.51	0.00	0.31	0.63	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	68.26	9.63	3.43	6.53	4.41	0.16	1.14	0.49	1.14
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	61.26	7.84	4.64	4.64	5.81	0.29	0.58	0.29	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	47.23	10.76	2.69	2.69	2.99	0.90	0.90	0.60	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	52.84	16.81	2.03	6.10	3.51	0.18	0.92	0.55	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	42.51	10.27	2.28	10.56	3.14	0.57	0.29	0.57	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	81.66	22.05	2.86	7.76	5.31	0.82	0.00	1.22	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	57.39	11.27	2.82	3.52	2.11	0.00	0.00	0.00	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	41.49	6.02	2.85	3.17	1.90	0.32	0.32	0.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	52.05	10.59	2.12	1.82	1.51	0.91	0.00	0.00	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	40.34	15.00	2.59	5.17	3.62	0.52	0.00	0.00	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	39.19	13.28	1.33	5.31	1.33	0.00	0.00	0.00	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	39.25	11.29	2.82	4.62	3.08	0.51	0.26	0.77	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	43.97	13.04	2.05	6.65	2.56	0.51	0.77	0.26	1.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	49.98	22.72	0.76	9.09	2.27	0.00	1.51	3.03	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	49.40	17.14	3.70	4.70	1.34	0.34	0.34	1.34	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	44.44	13.04	1.93	7.25	2.90	0.24	0.24	0.00	0.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	64.17	17.83	3.12	7.58	3.57	0.89	0.45	0.89	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	49.76	14.15	1.46	10.24	5.85	0.00	0.49	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	53.18	8.56	1.22	2.44	2.14	0.31	0.00	0.61	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	387.14	32.53	26.03	13.01	13.01	0.00	0.00	6.51	9.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	80.75	13.24	3.97	3.64	3.64	0.66	0.00	0.33	2.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	53.64	19.16	3.28	9.85	1.64	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	57.54	15.20	4.34	6.51	2.90	0.00	0.36	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	61.21	14.23	2.14	6.41	3.91	0.71	1.07	0.00	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	58.48	14.32	0.00	3.58	3.58	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	70.15	24.24	3.79	8.94	6.91	0.68	0.41	1.08	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	51.19	20.74	3.50	7.27	4.31	0.00	0.27	1.35	0.81
immature langerhans cells, donor1	11904-125F5	14.04	11.38	0.48	0.24	0.97	0.48	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	11.88	10.30	1.58	0.79	0.00	0.00	1.58	0.00	0.79
insula, adult, pool1	10039-101F3	34.16	8.80	1.80	3.12	1.70	0.47	0.09	0.28	0.85
keratoacanthoma cell line:HKA-1	10791-110H8	11.06	4.23	1.95	0.33	0.00	0.00	1.30	0.00	0.65
kidney, adult, pool1	10017-101C8	32.54	9.61	1.90	0.80	1.20	0.20	0.10	0.10	0.50
kidney, fetal, pool1	10045-101F9	21.01	5.45	1.70	0.92	0.57	0.42	0.00	0.07	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	69.73	17.89	4.54	2.41	2.98	0.43	0.00	0.14	1.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	15.21	5.53	1.38	0.69	0.14	0.00	0.41	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	57.44	9.91	4.22	3.49	2.39	0.55	4.04	2.20	0.55
left atrium, adult, donor1	10079-102A7	35.42	7.08	3.27	2.18	1.09	0.00	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	26.29	3.03	0.51	1.01	0.00	0.00	0.00	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	20.52	5.47	1.92	1.64	0.55	0.55	0.00	0.55	1.09
leiomyoma cell line:10964C	10569-108B2	28.02	7.18	2.51	4.31	0.72	0.00	0.36	0.72	1.08
leiomyoma cell line:15242A	10570-108B3	22.83	5.98	2.17	2.17	1.09	1.09	0.00	0.54	1.63
leiomyoma cell line:15425	10571-108B4	33.51	10.44	4.86	1.70	1.21	0.73	0.00	1.21	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	57.14	0.00	12.70	6.35	6.35	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	12.55	7.32	2.09	0.00	0.00	1.05	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	46.16	10.51	1.65	1.89	1.89	0.71	0.00	0.71	0.94
liposarcoma cell line:KMLS-1	10782-110G8	36.08	9.06	1.87	2.03	0.78	0.16	0.47	0.62	0.62
liposarcoma cell line:SW 872	10726-110A6	30.58	6.94	2.31	0.97	0.49	0.12	0.00	0.24	0.24
liver, adult, pool1	10018-101C9	27.87	13.13	1.30	1.62	0.97	0.49	0.00	0.32	0.32
liver, fetal, pool1	10086-102B5	10.35	4.70	1.88	2.82	0.94	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	42.43	11.08	1.46	3.50	2.92	0.58	0.15	0.44	0.29
locus coeruleus, adult, donor10252	10165-103B3	62.01	10.15	1.48	6.27	4.61	0.92	0.18	0.37	1.29
locus coeruleus, adult, donor10258	10375-105G6	42.32	6.77	1.69	3.67	1.97	0.28	0.56	0.28	0.28
locus coeruleus, newborn, donor10223	10362-105F2	60.99	13.88	1.68	6.31	4.63	0.42	0.00	0.84	0.42
lung adenocarcinoma cell line:A549	10499-107C4	32.25	11.35	6.09	4.43	0.83	0.42	0.55	0.42	1.25
lung adenocarcinoma cell line:PC-14	10408-106B3	31.71	6.89	2.76	0.69	0.69	1.38	0.69	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	52.59	7.12	3.82	3.82	1.85	0.13	0.40	0.79	0.92
lung, adult, pool1	10019-101D1	20.79	5.55	1.65	0.47	0.24	0.12	0.12	0.24	0.12
lung, fetal, donor1	10068-101I5	47.38	16.55	3.42	5.42	3.71	0.29	0.00	1.43	0.00
lung, right lower lobe, adult, donor1	10075-102A3	28.87	3.67	0.46	0.92	0.00	0.00	0.00	0.00	0.46
lymph node, adult, donor1	10077-102A5	21.77	6.63	1.42	0.47	0.00	0.00	0.00	0.00	0.47
lymphangiectasia cell line:DS-1	10727-110A7	15.34	8.99	3.29	3.29	0.66	0.00	0.88	0.66	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	17.81	17.21	1.51	3.17	0.45	0.30	0.75	0.00	0.60
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	36.53	13.59	0.00	1.70	1.70	0.00	2.55	0.00	0.00
mature adipocyte, donor1	12231-129F8	18.20	13.76	1.78	3.11	1.78	0.00	0.44	0.44	0.44
mature adipocyte, donor2	12232-129F9	30.51	14.53	0.42	1.04	2.91	0.42	0.42	0.42	0.42
mature adipocyte, donor3	12233-129G1	20.86	11.62	1.19	3.32	1.66	0.47	0.47	0.00	0.47
mature adipocyte, donor4	12234-129G2	35.27	15.27	3.42	6.05	2.63	0.79	0.26	0.00	1.05
maxillary sinus tumor cell line:HSQ-89	10414-106B9	30.50	13.10	2.38	2.38	1.43	0.71	0.00	0.00	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	25.94	11.28	0.00	2.26	2.26	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	48.55	9.56	2.02	1.66	3.49	0.00	0.00	0.37	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	29.23	10.48	0.32	1.59	1.59	0.32	0.00	0.95	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	69.94	8.53	4.69	5.12	4.69	0.43	0.43	1.28	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	49.95	12.32	2.36	1.52	2.03	0.68	0.17	0.51	0.68
medial temporal gyrus, adult, donor10252	10156-103A3	52.63	10.19	1.91	2.55	1.91	0.21	0.00	0.64	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	5.78	7.71	0.00	1.93	0.00	1.93	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	100.48	14.35	0.00	14.35	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	28.36	5.74	1.08	1.79	1.08	0.36	0.00	1.08	0.36
medulla oblongata - adult, donor10196	10174-103C3	49.32	8.44	1.30	2.60	3.24	1.95	0.65	1.30	1.30
medulla oblongata, adult, donor10252	10155-103A2	64.71	11.61	2.01	4.95	2.48	0.15	0.15	0.46	1.24
medulla oblongata, adult, pool1	10038-101F2	31.75	8.57	2.20	4.24	2.78	0.57	0.08	0.49	0.33
medulla oblongata, newborn, donor10223	10361-105F1	34.02	10.07	0.69	5.90	1.74	0.69	0.00	0.35	0.69
medulloblastoma cell line:D283 Med	10838-111E1	23.03	10.63	0.66	4.21	1.11	0.44	0.00	0.00	0.22
medulloblastoma cell line:ONS-76	10759-110E3	24.70	5.50	3.79	3.91	1.83	0.12	1.59	0.12	0.98
melanoma cell line:COLO 679	10514-107E1	20.27	5.46	2.87	1.87	1.58	0.57	0.14	0.57	0.29
melanoma cell line:G-361	10465-106H6	19.00	2.17	2.71	1.36	0.81	0.00	0.27	0.27	0.54
meningioma cell line:HKBMM	10691-109F7	30.39	3.62	2.53	1.27	0.18	0.00	0.18	0.72	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	22.03	17.62	2.64	5.29	2.64	0.88	0.00	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	25.66	16.07	2.85	2.33	1.56	1.56	0.00	0.26	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	31.45	8.90	3.53	1.99	0.61	0.77	0.31	0.31	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	26.72	7.09	3.64	2.00	1.09	0.00	0.00	0.18	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	22.36	7.45	2.07	3.31	1.66	0.83	0.00	0.41	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	31.47	6.04	2.39	2.11	1.55	0.14	0.28	1.26	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	25.61	7.51	1.16	2.31	1.16	0.96	0.39	0.19	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	28.46	11.11	2.78	2.78	2.78	0.00	1.39	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	34.84	10.81	3.43	2.92	2.57	0.17	0.17	0.51	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	20.93	6.21	3.45	2.88	0.81	0.00	0.35	0.23	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	24.01	7.30	2.92	1.59	0.66	0.27	0.00	0.53	0.80
mesenchymal precursor cell - cardiac, donor4	11755-123G9	27.14	5.81	2.57	1.49	1.35	0.41	0.14	0.00	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	33.57	4.98	4.27	4.27	0.85	1.14	0.00	0.43	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	24.70	7.25	1.98	0.66	0.00	0.33	0.00	0.66	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	31.96	6.23	3.04	1.66	0.42	0.97	0.00	0.42	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	35.61	4.89	2.44	1.05	1.40	0.35	0.00	1.05	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	25.72	7.76	4.29	2.04	1.22	0.20	0.00	1.02	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	20.49	4.31	1.44	1.08	0.36	0.36	0.00	0.36	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	23.90	7.45	2.90	0.93	0.52	0.31	0.00	0.41	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	14.36	5.02	1.82	1.14	1.37	0.68	0.00	0.23	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	48.67	9.65	5.45	7.55	2.94	1.68	0.00	0.84	2.10
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	23.16	6.72	1.79	1.05	0.75	0.45	0.00	0.45	1.20
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	32.74	8.14	2.54	1.93	0.96	0.53	0.00	0.79	0.44
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	22.46	8.47	1.47	0.74	1.10	0.74	0.00	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	14.59	4.58	1.43	1.72	0.86	0.00	0.29	0.00	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	49.68	11.79	4.63	4.21	2.11	0.84	0.42	0.42	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	22.83	6.39	1.83	5.48	2.28	0.00	0.00	0.00	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	34.53	6.65	3.58	3.33	2.05	0.51	0.26	0.77	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	30.89	6.54	3.66	3.14	0.79	0.26	0.00	0.52	1.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	26.50	8.32	2.46	1.85	0.92	0.31	0.00	0.31	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	29.42	7.30	2.59	2.59	1.41	0.00	0.24	0.00	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	22.34	8.12	3.05	2.37	1.69	0.00	0.34	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	29.08	4.72	1.57	1.18	0.79	1.18	1.18	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	25.02	8.80	3.71	2.32	0.93	0.46	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	34.03	9.52	5.77	2.88	2.02	0.29	0.29	0.00	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	30.56	7.59	2.90	2.01	1.34	0.22	0.89	0.00	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	28.36	4.81	1.68	2.64	1.68	1.20	0.00	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	35.20	4.40	0.73	1.47	0.73	0.73	0.00	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	30.88	6.71	3.36	2.69	1.01	0.34	0.34	0.34	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	34.39	5.32	2.46	1.64	0.41	0.41	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	27.06	8.16	3.44	3.44	1.29	0.43	0.00	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	19.14	10.94	0.00	2.73	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	5.16	5.16	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	27.28	7.47	4.55	5.52	0.97	0.00	0.00	0.65	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	21.82	4.36	0.00	1.45	1.45	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	18.66	7.46	0.53	2.67	1.07	0.00	0.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	27.80	4.91	1.64	3.27	0.00	0.00	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	27.60	6.61	1.94	2.72	1.55	0.39	0.78	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	16.79	2.10	2.10	8.39	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	21.86	2.98	4.97	3.97	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	28.60	4.77	4.77	4.77	4.77	0.00	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	22.53	3.56	1.19	1.78	1.78	0.59	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	18.28	9.75	0.00	2.44	1.22	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	23.44	5.07	1.90	5.07	3.80	0.00	0.63	0.00	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	22.07	3.79	2.41	5.17	1.03	0.00	0.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	21.49	6.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	35.93	3.99	0.00	7.98	0.00	0.00	3.99	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	10.33	3.44	3.44	6.89	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	19.97	5.30	0.81	3.67	2.04	0.00	0.41	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	19.07	3.18	0.79	3.18	0.79	1.59	0.00	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	17.69	4.13	0.59	2.95	0.59	0.00	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	24.94	6.55	0.31	4.36	0.62	0.00	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	13.37	8.02	0.00	2.67	1.34	0.00	1.34	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	10.64	7.10	0.00	2.37	1.18	0.00	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	25.68	5.14	0.00	2.57	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	9.64	4.13	2.07	4.82	2.75	0.00	0.00	0.69	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	17.81	12.86	0.49	1.48	1.48	0.00	0.00	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	17.94	11.22	1.12	1.12	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	22.90	19.08	0.64	3.18	1.91	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	18.94	8.46	1.21	1.21	1.61	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	19.63	8.72	2.18	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	13.94	10.14	0.00	1.27	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	21.85	9.10	1.21	2.43	2.43	0.00	0.00	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	27.11	9.04	0.00	9.04	0.00	4.52	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	28.83	10.71	1.65	2.47	1.65	0.82	0.82	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	28.77	8.33	1.98	3.77	1.98	0.60	0.20	0.40	0.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	18.50	7.46	2.60	3.57	0.97	0.32	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	13.24	8.15	2.04	3.06	3.06	0.00	0.00	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	30.17	13.93	2.32	3.87	0.77	0.00	0.00	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	27.40	6.38	3.31	0.94	0.24	0.24	0.24	0.71	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	31.51	10.66	4.17	2.55	0.70	0.46	1.16	1.39	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	25.64	8.55	0.00	8.55	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	26.10	7.09	2.47	4.73	1.44	0.31	0.21	0.41	0.31
mesothelioma cell line:Mero-25	10850-111F4	15.66	12.94	0.91	1.82	1.13	0.23	0.23	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	11.98	4.40	1.96	1.47	0.73	0.24	0.24	0.24	0.24
mesothelioma cell line:Mero-48a	10852-111F6	24.36	6.86	2.88	4.65	0.89	0.66	0.22	0.89	0.22
mesothelioma cell line:Mero-82	10853-111F7	25.23	7.88	1.05	1.58	1.31	0.53	0.00	1.05	0.00
mesothelioma cell line:Mero-83	10854-111F8	22.64	8.68	1.87	2.55	1.70	0.85	0.17	0.85	0.17
mesothelioma cell line:Mero-84	10855-111F9	15.42	4.55	2.78	2.27	1.01	0.25	0.25	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	19.05	6.21	1.45	3.52	0.83	0.21	1.24	0.41	0.83
mesothelioma cell line:NCI-H2052	10847-111F1	30.64	7.62	3.15	2.32	2.82	0.66	0.33	1.33	0.66
mesothelioma cell line:NCI-H226	10846-111E9	21.90	11.58	1.27	1.63	0.90	0.36	0.54	1.09	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	29.72	7.86	2.90	1.37	0.85	0.85	0.17	0.34	0.00
mesothelioma cell line:NCI-H28	10845-111E8	14.25	5.34	3.56	0.25	0.51	0.76	0.25	1.27	0.51
mesothelioma cell line:No36	10857-111G2	22.51	11.09	0.98	1.63	1.30	1.30	0.00	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	22.22	9.21	1.90	0.54	0.27	0.27	0.27	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	29.56	2.11	4.80	1.34	0.96	0.38	0.00	0.38	0.38
migratory langerhans cells, donor2	11902-125F3	22.71	5.13	2.56	0.24	1.10	0.49	0.00	0.37	0.37
migratory langerhans cells, donor3	11903-125F4	33.02	5.20	1.26	0.72	1.97	0.00	0.18	0.54	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	33.30	6.20	1.31	0.33	0.98	0.00	0.00	0.00	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	32.00	10.17	1.06	1.91	0.42	0.42	0.42	0.21	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	21.19	5.07	1.61	2.07	0.46	0.00	0.46	0.23	0.92
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	32.35	9.51	2.66	1.71	0.19	0.00	3.04	0.57	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	35.66	8.50	4.80	3.14	1.11	0.74	0.55	0.18	1.48
myeloma cell line:PCM6	10474-106I6	42.70	14.43	5.34	0.79	0.79	0.79	0.59	0.40	0.79
myxofibrosarcoma cell line:MFH-ino	10600-108E6	16.74	2.54	0.00	1.01	1.01	0.00	0.00	0.51	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	29.42	6.67	2.55	6.08	1.77	0.00	0.00	0.00	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	24.96	5.24	2.45	1.00	0.56	0.22	3.12	0.11	0.67
nasal epithelial cells, donor1, tech_rep2	12226-129F3	27.43	5.59	1.62	0.66	0.81	0.59	3.90	0.22	0.29
nasal epithelial cells, donor2	12227-129F4	19.87	5.52	1.66	0.55	0.55	0.55	3.86	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	62.58	16.33	1.84	5.29	4.37	0.23	0.23	0.00	1.15
neuroblastoma cell line:NB-1	10539-107G8	36.29	11.79	2.81	4.68	1.87	0.37	0.94	0.75	1.12
neuroblastoma cell line:NBsusSR	10607-108F4	74.65	38.59	3.16	10.97	6.54	1.69	0.42	0.42	0.21
neuroblastoma cell line:NH-12	10555-107I6	47.71	10.99	4.10	4.85	3.54	0.56	0.37	0.19	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	58.83	27.76	3.80	13.76	2.14	1.90	0.24	0.24	0.71
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	23.92	13.78	2.53	4.43	2.06	0.32	0.16	0.32	0.32
neuroectodermal tumor cell line:TASK1	10774-110F9	45.69	35.62	3.42	6.04	1.81	1.21	0.00	0.00	1.21
neuroepithelioma cell line:SK-N-MC	10728-110A8	18.44	16.53	0.64	6.36	0.00	0.64	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	19.96	5.86	1.60	1.06	0.80	0.27	0.27	0.00	0.00
neutrophil PMN, donor1	12133-128D9	29.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	39.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	37.88	18.94	0.00	9.47	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	43.97	13.53	2.54	3.72	3.38	0.34	2.71	1.52	1.18
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	50.43	5.60	4.80	5.60	1.60	0.80	0.00	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	29.82	8.98	3.21	2.89	2.24	0.00	0.32	0.96	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	24.96	7.88	2.36	1.31	0.79	0.53	0.00	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	35.62	12.56	3.00	2.91	2.16	0.19	0.09	0.09	0.94
occipital cortex - adult, donor10196	10172-103C1	30.91	12.36	0.00	2.06	0.00	0.00	0.00	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	45.08	12.08	0.54	5.90	1.88	0.27	0.00	0.27	0.81
occipital cortex, newborn, donor10223	10355-105E4	28.02	4.73	3.28	2.18	1.09	0.00	0.00	0.73	0.36
occipital lobe, adult, donor1	10076-102A4	33.59	11.02	1.84	3.94	0.79	0.26	0.00	0.26	1.57
occipital lobe, fetal, donor1	10073-102A1	172.50	9.87	3.86	25.75	15.45	0.86	0.43	1.72	4.29
occipital pole, adult, pool1	10036-101E9	10.88	5.68	1.10	0.55	0.32	0.32	0.00	0.08	0.24
olfactory region, adult	10195-103E6	30.19	6.88	0.76	2.10	1.72	0.19	0.00	0.57	0.96
optic nerve, donor1	10277-104E7	42.02	16.01	2.00	0.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	31.67	16.63	2.96	1.37	2.16	1.03	13.44	0.23	0.80
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	25.42	2.89	2.06	0.82	0.27	0.00	0.82	0.00	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	15.07	7.96	1.86	0.68	0.34	0.51	1.35	0.00	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	27.26	5.43	2.31	3.23	1.16	0.12	2.08	0.23	0.46
osteoclastoma cell line:Hs 706.T	10704-109H2	37.92	9.41	2.06	1.47	2.35	0.29	0.00	1.18	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	61.67	9.34	6.54	3.74	6.54	0.00	0.00	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	16.33	8.06	2.54	0.85	0.64	0.42	0.21	0.21	0.00
ovary, adult, pool1	10020-101D2	30.92	4.89	2.10	2.01	1.31	0.26	0.00	0.35	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	32.63	3.85	0.55	1.10	0.92	0.00	0.00	0.37	0.73
pancreas, adult, donor1	10049-101G4	21.63	5.64	1.88	2.82	0.94	0.00	0.00	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	12.30	8.11	1.96	0.84	0.00	0.00	0.28	0.28	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	33.05	13.46	2.90	3.41	1.36	1.02	0.17	0.68	0.85
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	52.49	5.63	4.47	2.15	0.99	0.17	0.00	0.83	1.32
paracentral gyrus, adult, pool1	10035-101E8	27.73	9.98	1.01	2.56	1.65	0.55	0.00	0.09	0.18
parietal cortex, adult, donor10258	10373-105G4	27.16	5.14	0.73	2.20	2.20	0.00	0.00	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	32.92	6.58	0.94	0.94	0.00	0.94	0.00	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	42.19	9.12	0.57	3.42	2.28	0.29	0.29	0.29	0.57
parietal lobe, adult, pool1	10034-101E7	25.03	8.20	1.23	1.85	1.76	0.26	0.09	0.09	0.35
parietal lobe, fetal, donor1	10072-101I9	155.17	8.73	4.85	19.40	14.55	0.00	0.00	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	37.76	9.35	1.87	1.50	0.75	0.37	0.00	0.37	1.12
parotid gland, adult	10199-103F1	20.97	25.28	1.85	1.23	1.23	0.00	0.62	0.62	0.00
penis, adult	10200-103F2	14.50	11.28	0.54	1.07	0.00	0.54	0.00	0.00	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	23.61	19.15	2.79	21.01	2.42	0.56	2.79	0.56	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	57.11	16.17	4.08	2.62	1.75	0.73	1.46	0.73	0.73
pineal gland - adult, donor10196	10179-103C8	25.80	7.10	0.65	1.29	1.29	0.65	0.00	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	79.36	14.21	4.15	2.96	3.55	2.37	0.00	0.59	1.18
pineal gland, adult, donor10258	10377-105G8	35.12	10.03	1.88	0.63	0.63	0.00	0.00	1.25	0.63
pituitary gland - adult, donor10196	10180-103C9	68.80	22.26	3.04	7.08	2.02	1.01	0.00	1.01	2.02
pituitary gland, adult, donor10252	10162-103A9	112.05	26.06	5.21	7.30	8.86	0.52	0.52	1.56	1.04
pituitary gland, adult, donor10258	10378-105G9	48.52	10.21	1.70	2.55	1.70	0.00	1.70	0.00	0.00
placenta, adult, pool1	10021-101D3	26.45	10.21	2.58	0.65	0.54	0.65	0.11	0.54	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	24.10	10.99	3.18	1.59	1.59	0.66	0.26	0.00	0.93
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	16.81	4.51	0.16	0.93	0.93	0.47	0.16	0.00	0.00
pons, adult, pool1	10033-101E6	45.01	10.33	2.84	5.08	4.05	0.95	0.00	0.09	1.03
postcentral gyrus, adult, pool1	10032-101E5	16.13	7.76	1.39	1.66	0.70	0.44	0.00	0.09	0.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	6.27	18.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	16.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	11.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	43.26	11.51	3.50	1.31	0.87	1.31	0.00	0.44	1.31
prostate cancer cell line:PC-3	10439-106E7	63.71	16.52	6.53	2.54	2.00	1.45	0.18	0.91	0.91
prostate, adult, pool1	10022-101D4	31.11	7.35	2.54	2.18	2.45	0.36	0.27	0.27	0.36
putamen, adult, donor10196	10176-103C5	62.32	12.75	2.83	2.36	1.18	0.71	0.00	0.00	1.42
putamen, adult, donor10252	10152-102I8	29.41	11.76	0.00	1.96	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	20.76	9.84	3.28	4.37	1.09	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	23.92	13.77	1.21	1.21	1.69	0.24	0.00	0.24	0.72
putamen, newborn, donor10223	10365-105F5	59.97	14.99	1.50	3.75	2.25	0.00	0.00	0.75	0.75
rectal cancer cell line:TT1TKB	10469-106I1	38.11	6.69	6.40	2.04	1.16	0.00	0.58	0.58	0.87
rectum, fetal, donor1	10067-101I4	40.34	9.74	1.39	1.39	2.78	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	45.37	7.21	2.76	1.06	2.33	1.06	0.00	0.21	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	57.99	6.63	3.31	2.90	2.07	0.41	0.00	1.24	0.41
retina, adult, pool1	10030-101E3	19.28	8.15	1.89	0.99	0.89	0.20	0.00	0.00	0.00
retinoblastoma cell line:Y79	10475-106I7	39.23	6.75	3.64	7.01	2.34	0.00	1.04	0.52	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	21.15	8.24	1.23	0.86	0.37	0.37	0.12	0.25	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	36.84	10.69	3.09	3.09	1.41	0.56	0.00	0.00	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	24.25	3.79	0.76	2.27	1.52	0.00	0.00	0.00	2.27
salivary acinar cells, donor1	11771-123I7	18.13	4.05	3.40	1.94	0.32	0.16	5.99	0.16	0.81
salivary acinar cells, donor2	11772-123I8	25.33	5.37	2.34	2.62	0.55	0.41	7.57	0.28	0.00
salivary acinar cells, donor3	11773-123I9	13.24	4.63	0.00	0.66	1.32	0.00	1.99	0.66	0.00
salivary gland, adult, pool1	10093-102C3	16.01	14.30	0.57	1.14	1.14	0.00	0.57	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	50.84	11.97	10.88	3.46	1.60	0.34	0.59	1.35	1.43
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	56.31	12.34	11.76	5.17	2.35	0.47	0.12	0.94	2.12
seminal vesicle, adult	10201-103F3	26.98	9.52	2.65	3.17	1.06	0.53	0.00	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	38.14	10.45	2.19	2.43	2.92	0.49	0.49	1.21	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	15.10	3.77	1.76	0.75	0.75	0.00	0.00	0.25	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	33.12	5.02	2.01	1.00	1.00	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	15.04	4.30	1.34	0.81	1.07	0.13	0.13	0.00	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	19.89	7.41	2.21	0.55	0.44	0.33	0.00	0.00	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	37.16	11.74	6.19	5.42	1.29	0.39	1.94	1.03	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	12.06	4.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	15.47	7.32	1.44	0.96	0.60	0.24	0.00	0.12	0.12
skeletal muscle, fetal, donor1	10066-101I3	28.14	6.03	3.02	1.01	2.01	0.00	0.00	1.01	1.01
skin, adult, donor1	10074-102A2	40.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	47.97	14.52	3.16	3.16	2.52	0.00	0.00	0.00	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	25.68	11.67	1.00	3.00	1.33	0.00	0.33	0.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	51.38	23.96	1.58	10.09	1.89	0.95	0.00	0.32	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	33.54	5.20	3.28	1.54	0.77	0.00	0.00	0.39	1.73
small cell lung carcinoma cell line:LK-2	10541-107H1	56.54	21.10	4.62	6.10	4.29	0.49	0.33	0.66	1.15
small cell lung carcinoma cell line:NCI-H82	10842-111E5	14.48	6.27	1.93	2.25	0.80	0.00	0.00	0.16	0.64
small cell lung carcinoma cell line:WA-hT	10562-108A4	55.35	23.32	1.96	6.76	2.18	0.22	1.09	0.87	0.87
small intestine, adult, pool1	10024-101D6	46.46	10.15	3.11	0.96	1.43	0.12	0.00	0.72	0.48
small intestine, fetal, donor1	10064-101I1	37.10	8.11	2.21	2.70	0.49	0.00	0.49	0.00	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	21.54	1.54	0.51	5.64	0.51	0.00	0.00	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	27.40	4.91	0.52	1.55	1.03	0.00	0.26	0.26	0.26
somatostatinoma cell line:QGP-1	10781-110G7	60.30	4.82	4.02	6.16	2.41	0.00	2.41	1.07	1.34
spinal cord - adult, donor10196	10181-103D1	66.07	12.39	1.38	2.98	5.28	0.23	0.46	0.23	0.92
spinal cord, adult, donor10252	10159-103A6	69.39	11.43	1.18	10.25	4.73	0.00	0.00	1.97	0.00
spinal cord, adult, donor10258	10369-105F9	38.05	8.30	2.77	2.77	2.08	0.69	0.00	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	46.96	17.08	1.22	7.93	2.44	0.00	0.61	0.61	0.61
spinal cord, newborn, donor10223	10359-105E8	66.59	18.37	4.13	7.81	7.35	0.00	0.92	0.92	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	28.97	4.18	2.09	1.79	1.79	0.45	0.00	0.45	0.60
spleen, adult, pool1	10025-101D7	29.96	10.13	2.09	1.10	1.10	0.11	0.22	0.33	0.77
spleen, fetal, pool1	10044-101F8	20.18	5.96	0.64	0.64	0.64	0.00	0.00	0.16	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	22.46	9.21	4.24	4.35	1.55	0.62	2.38	1.35	0.83
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	36.84	4.75	1.90	1.14	0.57	0.00	1.90	0.19	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	34.95	7.69	1.05	4.19	0.35	0.00	0.00	0.70	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	45.74	6.65	2.35	12.12	2.74	0.39	2.35	2.35	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	23.98	5.07	2.36	1.80	0.90	0.00	0.11	0.56	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	17.79	3.81	0.42	1.69	0.42	0.00	2.97	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	31.73	10.15	4.23	2.12	0.85	0.00	0.00	0.00	1.27
stomach, fetal, donor1	10062-101H8	17.09	7.48	1.07	1.07	0.00	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	22.79	11.39	2.85	1.14	1.14	0.00	0.00	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	72.28	11.01	0.83	6.44	4.78	0.62	0.00	0.21	0.62
substantia nigra, adult, donor10258	10371-105G2	19.14	6.72	1.03	0.00	2.59	1.03	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	19.78	12.72	1.41	4.24	4.24	0.00	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	26.59	11.46	2.98	3.90	1.83	0.46	0.00	0.23	1.60
temporal lobe, adult, pool1	10031-101E4	13.31	7.29	0.59	0.93	0.85	0.25	0.00	0.17	0.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	153.85	11.40	7.12	12.11	7.83	0.00	0.00	0.71	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	77.80	7.91	5.27	4.83	7.47	0.00	0.00	0.44	1.32
tenocyte, donor1	11763-123H8	33.86	5.93	1.75	3.84	1.40	0.70	0.35	0.00	1.40
tenocyte, donor2	11765-123I1	29.38	7.25	1.14	5.72	1.53	0.38	0.00	0.00	1.53
tenocyte, donor3	11768-123I4	34.10	5.19	1.11	4.08	1.48	1.11	0.74	0.37	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	48.44	6.46	0.68	2.55	4.25	0.00	0.34	1.02	1.02
teratocarcinoma cell line:NCR-G1	10798-110I6	64.90	12.64	2.93	9.56	3.08	0.31	0.00	0.15	0.77
teratocarcinoma cell line:PA-1	10807-111A6	37.19	8.37	3.10	8.83	2.01	0.15	0.15	0.00	0.77
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	26.15	7.74	2.92	4.06	1.02	0.13	0.13	0.51	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	37.82	6.05	1.13	1.89	0.76	0.00	0.00	0.38	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	26.17	3.38	6.54	5.89	1.53	0.22	0.55	0.98	0.87
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	45.27	2.28	1.95	2.93	1.95	0.00	0.00	0.00	0.00
testis, adult, pool1	10026-101D8	41.45	28.88	10.52	2.04	1.18	4.19	0.00	3.76	2.25
testis, adult, pool2	10096-102C6	46.01	36.99	10.37	0.90	2.71	10.37	0.00	4.51	0.90
thalamus - adult, donor10196	10168-103B6	43.06	9.94	4.42	2.21	2.21	1.10	0.00	1.10	1.10
thalamus, adult, donor10252	10154-103A1	75.95	13.91	2.19	5.31	4.22	0.78	0.00	0.78	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	33.87	4.62	0.00	3.08	4.62	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	26.19	6.42	1.32	1.65	2.31	0.49	0.00	0.16	0.33
thalamus, newborn, donor10223	10366-105F6	25.89	7.48	1.73	0.58	3.45	0.00	0.00	0.58	1.15
throat, adult	10209-103G2	18.97	7.24	1.75	2.00	0.75	0.00	0.00	0.50	0.00
throat, fetal, donor1	10061-101H7	42.66	11.58	1.52	3.66	2.44	0.30	0.30	0.30	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	38.75	9.74	1.99	2.98	0.99	0.20	0.20	0.60	1.19
thymus, adult, pool1	10027-101D9	28.13	12.43	2.29	1.39	0.99	0.20	0.50	0.40	0.30
thymus, fetal, pool1	10043-101F7	35.64	13.09	2.49	2.29	1.56	0.83	0.42	0.21	0.62
thyroid carcinoma cell line:KHM-5M	10776-110G2	35.23	6.38	1.86	1.46	1.33	0.53	0.00	0.13	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	66.49	14.11	5.87	1.54	1.68	0.70	0.28	0.28	0.84
thyroid, adult, pool1	10028-101E1	33.59	14.28	2.15	1.87	1.40	0.28	0.00	0.09	0.56
thyroid, fetal, donor1	10060-101H6	30.85	17.40	0.79	1.58	1.05	0.53	0.00	0.26	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	6.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	16.05	11.63	1.40	0.70	0.23	0.23	0.47	0.00	0.00
tongue, fetal, donor1	10059-101H5	38.23	13.40	1.97	6.70	1.97	0.79	0.00	0.39	0.00
tonsil, adult, pool1	10047-101G2	21.54	9.42	2.20	0.90	1.00	0.70	0.10	0.10	0.20
trachea, adult, pool1	10029-101E2	23.89	8.92	2.04	1.23	1.06	0.98	0.25	0.25	0.33
trachea, fetal, donor1	10058-101H4	30.78	7.69	0.38	0.38	0.38	0.00	0.00	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	23.38	6.38	1.77	1.06	0.00	0.71	0.00	0.35	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	63.12	10.84	5.88	4.96	2.43	0.91	1.22	0.61	0.91
transitional-cell carcinoma cell line:JMSU1	10492-107B6	37.29	11.91	8.30	2.98	1.41	0.47	0.31	0.78	1.10
tridermal teratoma cell line:HGRT	10694-109G1	22.83	5.71	0.00	0.00	0.00	0.00	0.00	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	50.79	6.52	4.57	2.79	0.93	0.34	1.44	0.42	1.02
umbilical cord, fetal, donor1	10057-101H3	39.64	6.26	2.09	2.09	0.00	0.00	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	23.89	9.90	2.22	1.88	3.24	0.00	0.00	0.00	0.00
uterus, fetal, donor1	10055-101H1	42.49	6.66	2.05	1.54	1.02	0.51	0.00	0.00	1.02
vagina, adult	10204-103F6	25.20	4.52	0.65	0.65	0.65	0.00	0.65	0.00	0.00
vein, adult	10191-103E2	22.80	9.43	1.97	1.10	0.44	0.66	0.00	0.00	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	23.77	5.34	5.07	3.20	0.27	0.27	0.53	0.80	0.53